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Biotechnology and Consumer Decision-Making
Joanna K. Sax*
ABSTRACT
Society is facing major challenges in climate change, health care and
overall quality of life. Scientific advances to address these areas continue to
grow, with overwhelming evidence that the application of highly tested forms of
biotechnology is safe and effective. Despite scientific consensus in these areas,
consumers appear reluctant to support their use. Research that helps to
understand consumer decision-making and the public’s resistance to
biotechnologies such as vaccines, fluoridated water programs and genetically
engineered food, will provide great social value. This article is forward-thinking
in that it suggests that important research in behavioral decision-making,
specifically affect and ambiguity, can be used to help consumers make informed
choices about major applications of biotechnology. This article highlights some
of the most controversial examples: vaccinations, genetically engineered food,
rbST treated dairy cows, fluoridated water, and embryonic stem cell research. In
many of these areas, consumers perceive the risks as high, but the experts
calculate the risks as low. Four major thematic approaches are proposed to create
a roadmap for policymakers to consider for policy design and implementation in
controversial areas of biotechnology. This article articulates future directions
for studies that implement decision-making research to allow consumers to
appropriately assign risk to their options and make informed decisions.
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INTRODUCTION
Despite overwhelming scientific evidence supporting the
application of biotechnology to address major social issues, consumers
are resisting policies that apply science to solve major challenges. This
article utilizes theories in behavioral decision-making research not
only to articulate why consumers may be hesitant to accept
biotechnology, but proposes to deeply study and analyze ways to
assuage the public’s concerns. Consumers are bombarded with
conflicting information regarding each area of technology and, not
surprisingly, struggle to separate the wheat from the chaff. A
tremendous amount of resources is dedicated to evaluating risk, yet
not enough attention is given to how consumers perceive risk. This
lack of attention creates a major problem for policy implementation.
In other words, expert analysis of risk is not translating into consumer
perceptions of risk. This article seeks to present a roadmap of studies
that implement decision-making research to translate the empirical
evidence of risk analysis in ways that allow consumers to appropriately
assign risk to various areas of biotechnology, such as vaccines.
Every day most of us experience the benefits of science and, in
particular, biotechnology. Even the small parts of our days are
influenced by biotechnology, such as pouring milk in our morning
coffee, providing food for ourselves and our families, drinking water,
and avoiding otherwise contractible diseases. These daily routines are
enabled and facilitated by various scientific advances: rbST treated
dairy cows, conventional and genetically engineered food, fluoridated
water, and vaccines, respectively.
Policies implementing these
technologies, based on scientific evidence, provide great social value,
even though consumers may not fully understand the underlying
technology. Some consumers may not even think about the
underlying technology, unless and until they are provided with
information—or mis-information—that causes great concern.
Public health officials tout many of the advances in science as
some of our greatest achievements, particularly fluoridated water and
vaccination programs.1 In general, public health officials promote
group rights and look at the population as a whole when analyzing
benefits. For example, if vaccination programs all but eliminate an
otherwise serious disease, such as smallpox, with little to no otherwise
1

See, e.g., Community Water Fluoridation, CTR. FOR DISEASE CONTROL,
http://www.cdc.gov/fluoridation/index.htm (last updated July 29, 2015); Why Are
Childhood
Vaccines
So
Important?,
CTR.
FOR
DISEASE
CONTROL,
http://www.cdc.gov/vaccines/vac-gen/howvpd.htm#why (last updated May 19, 2014)
[hereinafter CDC, Why Are Childhood Vaccines So Important?].

SAX (DO NOT DELETE)

436

2/16/2017 2:44 PM

SETON HALL LAW REVIEW

[Vol. 47:433

measurable harm, then the benefit greatly outweighs the risk.2
Increasingly, however, calls for the removal of rbST from dairy cows,
elimination of fluoridated water, labeling of food based on safety
concerns, and personal exemptions from vaccination programs are
heard from consumers. It is important to understand not only why
these consumers raise concerns (e.g., whether it is from marketing or
political campaigns) but also, how to allay their concerns—especially
if the concerns are based on inchoate fears. This tension between
widespread policy implementation and opposition by individuals
creates issues for innovation and policy implementation. This article
attempts to articulate and understand consumer preference as it
relates to the application of biotechnology. In the United States, the
federal government invests the lion’s share of resources in assessing
risk, but there remains a pressing need for investment in
understanding why consumers perceive risk differently than expert
analysis.3
Given the strong scientific evidence supporting many of the
widespread programs, such as vaccines and fluoridated water, we, as a
society, need to understand why some consumers are resisting these
programs, especially the mandatory programs.4 Efforts are underway
to remove fluoride from public water supplies, for example.5 The
discord with the application of biotechnology is not limited to
widespread public health programs; it is also strong in other areas such
as genetically engineered food, rbST treated cows, funding for
embryonic stem cell research, and others. This article tackles these
issues and articulates a theme that is seen throughout all of these
controversial areas, which is that consumers are inappropriately
assigning risk to the application of these scientific advances. To do
this, this article builds on decision-making research to suggest reasons
why consumers are averse to the implementation of policies that apply
biotechnology.
In risk perception research, scholars study consumer preferences

2

See,
e.g.,
Why
Immunize?,
CTR.
FOR
DISEASE
CONTROL,
http://www.cdc.gov/vaccines/vac-gen/why.htm (last updated Sept. 23, 2014)
[hereinafter CDC, Why Immunize?].
3
Cf. WERNER TROESKEN, THE POX OF LIBERTY 1, 14–38 (2015).
4
See, e.g., George Johnson, The Widening World of Hand-Picked Truths, N.Y. TIMES,
Aug. 24, 2015.
5
See Stephanie Innes, Cavities Again? Blame the Tucson Water System. . ., ARIZ. DAILY
STAR, Nov. 2, 2014, http://tucson.com/news/science/health-med-fit/cavities-againblame-the-tucson-water-system/article_33d26ed3-2fb0-5385-b14c-e97630237f4e.html
(“An increasingly vocal opposition to fluoridated water has emerged in recent years,
fueled by a distrust in government.”).
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for various technologies.6 A profound example of a disconnect
between scientists and consumers is the perception of risk of nuclear
power.7 While experts generally find nuclear power to be a safe and
clean source of energy, consumers perceive it as a highly risky activity.8
Understanding these perceptions of risk is a robust area of study and
is important for both appreciating and assuaging public concerns and
fears. Three Mile Island, the notorious nuclear power plant leak, is oft
cited for qualifying the public push-back to nuclear power plants.9
Empirical data, however, demonstrates that rates of cancer and other
related diseases are no greater for the population surrounding Three
Mile Island compared to the population in general.10 In other words,
there is no measurable health harm attributable to the leak. Despite
this, research shows that consumers find nuclear power plants to be
risky, with cost playing an additional role.11 As such, the public
perceptions and concerns have all but eliminated the nuclear power
industry.12 This has occurred despite expert opinion on safety and
utility to the contrary.13 Perhaps other energy industries have a vested
interest in feeding consumer concerns; or perhaps the debate about

6

Paul Slovic, Perception of Risk, 236 SCI. 280, 281 (1987) [hereinafter Slovic,
Perception of Risk]. The author thanks a colleague for introducing Paul Slovic’s work to
allow the author to understand and incorporate components of risk perception
research into the author’s research (personal communication).
7
Id.
8
Id. (citing published articles therein).
9
See Backgrounder on the Three Mile Island Accident, U.S. NUCLEAR REG. COMMISSION,
http://www.nrc.gov/reading-rm/doc-collections/fact-sheets/3mile-isle.html
(last
updated Dec. 12, 2014) (“A combination of personnel error, design deficiencies, and
component failures caused the Three Mile Island accident, which permanently
changed both the nuclear industry and the NRC. Public fear and distrust increased,
NRC’s regulations and oversight became broader and more robust, and management
of the plants was scrutinized more carefully.”).
10
Id. (“[C]omprehensive investigations and assessments by several well respected
organizations, such as Columbia University and the University of Pittsburgh, have
concluded that in spite of serious damage to the reactor, the actual release had
negligible effects on the physical health of individuals or the environment.”).
11
See, e.g., Bryan Walsh, Nuclear Energy is Largely Safe. But Can it be Cheap?, TIME
(July 8, 2013), http://science.time.com/2013/07/08/nuclear-energy-is-largely-safebut-can-it-be-cheap/ (“And while fears of accidents and radioactivity clearly play a role
in that decline, cost is an even bigger factor.”).
12
See id. (“[I]n the U.S. and much of the rest of the developed world, nuclear
energy is in retreat, with new reactors on hold and aging ones being retired. And while
fears of accidents and radioactivity clearly play a role in that decline, cost is an even
bigger factor.”).
13
See id. (“Accidents are rare, and those that have occurred—including the partial
meltdown in Fukushima, Japan, in 2011—have resulted in few deaths. On a megawattper-megawatt basis, nuclear kills fewer people than almost any other source of
electricity . . . .”).
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which source of energy is better—such as wind, solar, natural gas, or
nuclear—makes it challenging for consumer decision-making, given
the limitations of a typical consumer’s knowledge about highly
scientific information.
In other words, the advantages and
disadvantages of each type of energy source require complicated
discussions that may require expertise.
A similar disconnect about the assignment of risk is occurring in
the application of biotechnology. Sectors of the public are wary of
various programs and technologies despite scientific consensus to the
contrary. Understanding these perceptions is critical to creating
policies that are acceptable to consumers––so that vaccinations
programs, for example, do not face the same type consumer objections
as nuclear power plants. Research is needed to get a foothold on
understanding not only why consumer perceptions are different from
expert analysis but to also evaluate approaches that allow consumers
to appropriately assign risk.
This article addresses the important question of how to create
policies that not only reap the benefits of biotechnology to solve major
challenges, but also have the ability to be accepted and trusted by
consumers. To begin this evaluation, Part I describes theories that
elucidate how consumers appropriately or inappropriately assign risk
as part of decision-making. This article draws on scholarship that
advances two general theories––affect and ambiguity.14 After this
general explanation of decision-making theories, this article turns to a
description of some major areas of biotechnology that are hotly
debated. Part II thus describes the contours of debates surrounding
vaccinations, genetically engineered food, rbST treated dairy cows,
fluoridated water programs and embryonic stem cell research––this
analysis includes both the scientific consensus and the various
consumer perceptions. Finally, Part III combines the decision-making
theories with the scientific areas to articulate four themes to be
considered for creating policies that assuage public concerns and
perceptions. These themes provide an overarching approach to
understanding and addressing consumer concerns regarding the
implementation of controversial areas of technology. The four themes
are: (1) Separate the wheat from the chaff: allow consumers to make
informed choices; (2) Scientific uncertainty is different than risk; (3)
Explore different methods of communication that consider the role of
affect and ambiguity; and (4) Address the difference between values,
14

Paul Slovic et al., The Affect Heuristic, 177 EUR. J. OF OPERATIONAL RES. 1333, 1333
(2007) [hereinafter Slovic, The Affect Heuristic]; Daniel Ellsberg, Risk, Ambiguity, and the
Savage Axioms, 75 Q. J. OF ECON. 643, 643–69 (1961).
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affect and ambiguity in decision-making. Within each theme, however,
is a detailed discussion of the various similarities and differences
between and among each example (vaccines, genetically engineered
food, rbST, fluoridated water and embryonic stem cell research). Each
example requires specific attention and proposals for conducting
studies geared towards the individual issues raised, which are included
herein. This article builds on many studies in the sciences, including
decision-making research and the basic sciences, to promote future
directions that acknowledge the problems we face and seeks to allow
consumers to make informed decisions.
I. DECISION-MAKING THEORIES
How consumers assign risk to new technologies is a key
component to understanding decision-making. Two major theories––
ambiguity and affect––help elucidate how consumers assign risk,
especially when some information is unknown.
A. Ambiguity
Ambiguity is defined as “a quality depending on the amount, type,
reliability and ‘unanimity’ of information, and giving rise to one’s
degree of ‘confidence’ in an estimate of relative likelihoods.”15 Daniel
Ellsberg, the pioneer of the ambiguity theory, questioned the ability to
predict a particular decision when uncertainty exists.16 In his
hypothetical experiment, Ellsberg presented subjects with two urns:
the first urn contained a known mixture of colored balls (fifty percent
red and fifty percent black) and the second urn contained an unknown
mixture (although unknown to subjects, it actually contained the same
percentage). Subjects would be paid $100 if they selected a red ball
and $0 if they selected a black ball.17 When asked which urn they
wished to choose from, subjects preferred choosing from urn one
(with the known ratio).18 That is, subjects preferred to bet on the urn
with the known risk rather than the second urn, which contained an
unknown risk.19 Put differently, subjects tend to prefer to bet on a
known probability rather than an unknown probability.20 This
phenomenon, where subjects are more likely to choose a known risk
15

Ellsberg, supra note 14, at 657.
Id. at 656.
17
Id. at 650.
18
Id. at 657.
19
Id. at 657–58; see also Laura L. Blaisdell et al., Unknown Risks: Parental Hesitation
about Vaccination, 36 MED. DECISION MAKING 479, 480 (2016).
20
Blaisdell, supra note 19.
16
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compared to an unknown risk underscores the theory of ambiguity in
decision-making.21 Numerous studies have tested this directly or
indirectly.22 As discussed in greater detail in Part II, this is particularly
relevant to how consumers perceive risk with new technology,
especially when all the risks are unknown.
Research supporting ambiguity in decision-making also focuses
on how subjects make decisions when uncertainty for the possible
outcome is not known.23 In other words, if a person is unsure of a
particular outcome, the state of potential probabilities is ambiguous.24
Studies have shown that people are averse to ambiguity—which means
that if the probability of a risk is presented in an ambiguous way,
subjects tend to be averse to toward the ambiguity.25 For example,
“[w]hen ambiguity about vaccination risk was caused by salient missing
information about the risks from vaccination—a child had a high risk
of being harmed by the vaccine, or no risk at all, but it was impossible
to find out which—subjects were more reluctant to vaccinate.”26
Subjects demonstrate aversion to ambiguous information—especially
when they perceive that they cannot assign a risk to a particular
outcome. In other words, consumers may inappropriately assign risk
when presented with ambiguous information. Examples of ambiguity
aversion are discussed in Part II.
B. Affect
Affect is defined as “the specific quality of ‘goodness’ or ‘badness’
(a) experienced as a feeling state (with our without consciousness) and
(b) demarcating a positive or negative quality of a stimulus.”27 In other
words, affect refers to the reliance on a feeling to guide decisionmaking.28 That is, the “faint whisper of emotion” guides decisionmaking; “[p]leasant feelings motivate actions that people will
anticipate will reproduce those feelings [and] [u]npleasant feelings
21

Id.
See, e.g., id.; Joanna K. Sax & Neal Doran, Food Labeling and Consumer Association
with Health, Safety and Environment, 44 J. L. MED. & ETHICS 630, 635–37 (2016)
[hereinafter Sax & Doran]; Colin Camerer & Martin Weber, Recent Developments in
Modeling Preferences: Uncertainty and Ambiguity, 5 J. OF RISK AND UNCERTAINTY 325, 333–
41 (1992) (describing empirical studies of ambiguity).
23
See Camerer & Weber, supra note 22, at 325.
24
See id. at 331 (“When a person is not sure what the distribution of probabilities
is, we call the state probabilities ambiguous.”).
25
See id. at 354.
26
Id.
27
Paul Slovic & Ellen Peters, Risk Perception and Affect, 15 CURRENT DIRECTIONS IN
PSYCHOL. SCI. 322, 322 (2006) [hereinafter Slovic, Risk Perception and Affect].
28
See id.
22
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motivate actions that people will anticipate will avoid those feelings.”29
Important research by Paul Slovic and others shows that affect impacts
how subjects correlate perceptions of risks with benefits.30 That is,
subjects perceive activities that have high benefits as low risk and vice
versa. By way of example, in a study conducted by Alhakami and Slovic,
subjects demonstrated this inverse relationship with pesticide use—,
i.e., high risk and low benefit.31 These results were linked to how
subjects viewed the goodness or badness of the activity and assigned
risk accordingly.32 According to Slovic and Peters, this finding
demonstrates that “[i]f their feelings toward an activity are favorable,
they tend to judge the risks as low and the benefits as high; if their
feelings toward the activity are unfavorable, they tend to make the
opposite judgment—high risk and low benefit (i.e., the affect
heuristic).”33 Referring back to the difference of risk perceptions
regarding nuclear energy (which was discussed in the introduction),
Slovic and colleagues suggest that affect underscores the reasons why
the feeling of dread leads people to assign a high risk to exposure to
radiation from nuclear power plants as compared to exposure to
radiation from x-rays.34 As noted by Slovic and Peters, “an assessment
not shared by risk experts.”35
In decision-making, consumers may not always maximize
expected utility; rather, they may ask themselves how they feel about a
particular decision.36 Or, if consumers are experiencing a particular
feeling at a given time, this emotional state will impact their decision
processes.37 For example, emotional states such as anger and arousal

29

Id.
See id. at 323; Slovic, The Affect Heuristic, supra note 14, at 1333–34.
31
Slovic, Risk Perception and Affect, supra note 27, at 323 (referring to study
conducted by Alhakami and Slovic).
32
Id.
33
Id. (internal citation omitted).
34
Id.
35
Id.
36
See Paul Slovic, What’s Fear Got to Do with It? It’s Affect we Need to Worry About, 69
MO. L. REV. 971, 973 (2004) [hereinafter Slovic, What’s Fear Got to Do with It?] (“As life
became more complex and humans gained more control over their environment,
analytic tools were invented to ‘boost’ the rationality of our experiential thinking.
Subsequently, analytic thinking was placed on a pedestal and portrayed as the epitome
of rationality. Affect and emotion were seen as interfering with reason.”); Ellen Peters
et al., Affect and Decision Making: A “Hot” Topic, 19 J. BEHAV. DECISION MAKING 79, 80
(2006) (“First, affect can act as information: at the moment of judgment or choice,
decision makers consult their feelings about a choice and ask, ‘How do I feel about
this?’”).
37
Peters et al., supra note 36, at 81–83.
30
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impact how subjects make decisions.38 Importantly, feelings come on
quickly—and this surge can impact decision-making at a particular
point in time.39 These feelings impact risk assessment.40
Survival requires that humans assess risk from different situations
and then either avoid risky situations or design around them.41 In the
contemporary times, consumers are assessing risk as they are exposed
to various technologies; but given the complicated nature of
technology, it can be challenging for a typical consumer to fully
evaluate and assign risk to a new technology. “The dominant
perception for most Americans (and one that contrasts sharply with
the views of professional risk assessors) is that they face more risk today
than in the past and that future risks will be even greater than
today’s.”42 Understanding how consumers assign risk—and what
underlies this decision-making process—is important for
implementing and regulating policies that relate to health and safety.43
C. Ambiguity, Affect and Decision-Making
Decision-making is a complicated process. Although it cannot be
neatly condensed into these two theories—ambiguity and affect—they
can be (and have been) empirically tested and used to assist with
understanding consumer perceptions of technology.44 Both of these
theories can operate at the same time, especially because they both
apply to perceptions of risk. In the case of biotechnology, unknown
risks exist and so we need to understand how consumers perceive and
weigh those risks.
In the Internet age, consumers can Google anything and a wide
variety of information will be presented. If, for example, a consumer
38

Id. at 81.
See Slovic, What’s Fear Got to Do with It?, supra note 36, at 971.
40
See id. at 976 (“Evidence of risk as feelings was present (though not fully
appreciated) in early psychometric studies of risk perception. Those studies showed
that feelings of dread were the major determiner of public perception and acceptance
of risk for a wide range of hazards.”).
41
See Slovic, Perception of Risk, supra note 6, at 280.
42
Id.
43
Id. (“The basic assumption underlying these efforts is that those who promote
and regulate health and safety need to understand the ways in which people think
about and respond to risk.”).
44
This article does not suggest that other theories and approaches are not also
involved, but instead advocates that the role of affect and ambiguity are understudied
in this area. For other approaches, see, for example, John Bohannon, Government
‘Nudges’ Prove their Worth, 352 SCI. 1042, 1042 (2016), for a discussion of successful
government nudges; see also Dan M. Kahan, A Risky Science Communication Environment
for Vaccines, 342 SCI. 53, 53–54 (2013), for a discussion addressing the role of cultural
cognition in risk assessment.
39
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searches for information regarding vaccinations and autism, websites
will pop up that promote this linkage. Despite the scientific consensus
that vaccinations do not cause autism, the public perception still exists.
When parents are making a decision as to whether to vaccinate their
child or not, they are weighing risks. Consumers may, for example,
have difficulty assigning risk to vaccinations if they perceive there are
unknowns (ambiguity) or that vaccinations may hurt their children
(affect).
Consumers may be subject not only to conflicting
information, but may also have trouble evaluating whether the source
is credible. If one medical professional touts a linkage between
vaccines and autism, then how do consumers weigh information from
other medical professionals that no linkage exists?
The next section turns to examples in biotechnology where
consumers may have difficulty assigning risk either because the
information is unknown or because information impacts the feelings
they experience as they make a decision.
II. AREAS OF BIOTECHNOLOGY THAT FACE CONSUMER
OPPOSITION
This section addresses some controversial examples of
biotechnology wherein public calls for regulation or elimination are
not in accord with the scientific consensus. The underlying science of
each area is described in order to guide the discussion regarding what
risks are known and unknown. This section will also highlight where
the controversy about each topic exists.
A. Vaccines
The development of vaccines to eradicate disease is considered a
medical breakthrough.45 Smallpox, polio, measles, mumps, rubella,
and other diseases that crippled and killed people can now be avoided
through the use of vaccines.46 Vaccines are widely supported by public
health officials as a main mechanism to avoid the spread of disease.47
Vaccines are regarded as safe and effective.48
45

See Achievements in Public Health, 1900–1999 Impact of Vaccines Universally
Recommended for Children––United States, 1990–1998, 48 MORBIDITY & MORTALITY WKLY.
REP. 243, 243–48 (1999), https://www.cdc.gov/mmwr/preview/mmwrhtml/000568
03.htm (“Vaccines are one of the greatest achievements of biomedical science and
public health.”).
46
See CDC, Why are Childhood Vaccines So Important?, supra note 1.
47
See CDC, Why Immunize?, supra note 2.
48
Vaccine Safety, CTR. FOR DISEASE CONTROL, http://www.cdc.gov/vaccinesafety/
index.html (last updated Nov. 2, 2015) [hereinafter CDC, Vaccine Safety] (“Data show
that the current U.S. vaccine supply is the safest in history.”).
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Vaccines are small doses of a dead or attenuated (not able to
reproduce) virus. Upon administration of a vaccine, the body’s
immune system generates an immune response by creating antibodies
to kill the virus.49 In the case of vaccines, the injected virus is either
dead or attenuated, so the disease can never manifest but the immune
reaction is activated nevertheless.50 Once the antibodies are created
the immune system now has a memory bank, which can be analogized
to a filing system, as to how to fight that particular virus.51 This is why
the term “immunized” is used. Now, if the body ever encounters the
actual virus through real contact, the immune system can return to its
files, quickly call up the particular antibody, and efficiently fight off the
virus before the virus can infiltrate and replicate in the body.52 Put
differently, vaccines teach the body how to defend against particular
diseases, if exposed.
Vaccines are not without any risk. Patients can have allergic
reactions or infection at the site of injection. A National Vaccine Injury
Compensation Program, established by the US government,
compensates patients who are injured as a result of vaccines.53 In
balancing the risk to benefit ratio, the overwhelming response by
physicians and public health officials is to support vaccine regiments.
About twenty years ago, a research team published a report in the
Lancet identifying a connection between vaccines and autism.54 This
research paper—which later had to be retracted because the data did
not support the conclusion—still managed to instigate an enormous
anti-vaccination campaign. Individuals claimed that the mandatory
49

See Understanding How Vaccines Work, CTR. FOR DISEASE CONTROL,
http://www.cdc.gov/vaccines/hcp/conversations/downloads/vacsafe-understandcolor-office.pdf (last visited May 24, 2016) (“Vaccines help develop immunity by
imitating an infection. This type of infection, however, does not cause illness, but it
does cause the immune system to produce T-lymphocytes and antibodies. . . . Once
the imitation infection goes away, the body is left with a supply of ‘memory’ Tlymphocytes, as well as B-lymphocytes that will remember how to fight that disease in
the future.”).
50
See, e.g., id. (describing live, attenuated viruses and inactivated viruses).
51
See, e.g., id. (describing the five main types of vaccines commonly administered).
52
Id. (“Once the imitation infection goes away, the body is left with a supply of
‘memory’ T-lymphocytes, as well as B-lymphocytes that will remember how to fight that
disease in the future.”).
53
See National Vaccine Injury Compensation Program, HEALTH RES. & SERVS. ADMIN.,
http://www.hrsa.gov/vaccinecompensation/ (last updated Feb. 2016).
54
A.J. Wakefield et al., Ileal-Lymphoid-Docular Hyperplasia, Non-Specific Colitis, and
Pervasive Developmental Disorder in Children, 351 THE LANCET 637, 637–41 (1998),
http://www.thelancet.com/journals/lancet/article/PIIS0140-6736(97)11096-0.pdf.
It is critical to note, however, that this misleading publication was subsequently
retracted.
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vaccination programs violated parental autonomy—especially given
the concerns about the link between vaccines and autism. Despite the
retraction of the Lancet paper and many dozens of studies
demonstrating that vaccines are not linked to autism, this view that
vaccines cause autism persists. An Internet search for “vaccines and
autism” provides results that can tell a parent anything that s/he wants
to believe, regardless if it is based on scientific evidence. Put
differently, despite scientific evidence that vaccines are not linked to
autism, consumers may still read information on the Internet that says
otherwise.55
Both individual and religious objections to vaccines led to the
passage of state laws exempting children from mandatory vaccination
requirements. Most notably, California was at the forefront of the
individual exemptions. Over time, more and more children stopped
receiving vaccines. In 2014, a major measles outbreak at Disneyland in
southern California called attention to the dangerous realities that can
occur when people stop being vaccinated.56 Public health officials
believe that due to vaccination exemptions, an outbreak occurred.
This is particularly troubling for parents who cannot vaccinate their
children for medical reasons and rely on the requisite level of herd
immunity.57 In response to this outbreak, on June 30, 2015, California
Governor Jerry Brown signed SB277, which removed the individual
exemptions for children, leaving only a medical exemption.58
Laura Blaisdell and colleagues conducted an insightful study by
interviewing focus groups to understand why parents might be hesitant
or reject vaccinating their children.59 A number of themes were
55

See, e.g., Whet Moser, Why Do Affluent, Well Educated People Refuse Vaccines?,
CHICAGO (Mar. 26, 2014), http://www.chicagomag.com/city-life/March-2014/Why-IsVaccine-Refusal-More-Prevalent-Among-the-Affluent/ (“Social networks (actual ones)
seem to be incredibly important in forming opposition to vaccines, either in whole or
in part: ‘in this study, parents who didn’t follow CDC guidelines were more likely to
have extensive “source networks” that included books, blogs, websites, and magazine
articles to which they turned for vaccine-related information.’”).
56
Measles, CAL. DEP’T OF PUB. HEALTH, https://www.cdph.ca.gov/HEALTHINFO
/DISCOND/Pages/Measles.aspx (last updated Feb. 2, 2016).
57
See, e.g., NICOLE HUBERFELD, ELIZABETH WEEKS & KEVIN OUTTERSON, THE LAW OF
AMERICAN HEALTH CARE 1, 12–13 (2016).
58
See Letter from Jerry Brown, Governor, State of Cal., to Members of Cal. State
Senate (June 30, 2015), https://www.gov.ca.gov/docs/SB_277_Signing_Message.pdf;
see also Editorial, California Settles the Vaccination Question, L.A. TIMES (June 30, 2015,
2:43 PM), http://www.latimes.com/opinion/editorials/la-ed-vaccination-bill-signedinto-law-in-california-20150701-story.html (“With Gov. Jerry Brown’s swift signature
Tuesday on a tough new mandatory vaccination bill, the state has established itself as
a national leader on public health.”).
59
Blaisdell, supra note 19, at 479–80.
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confirmed and elucidated among Vaccine Hesitant Parents (VHPs).60
First, VHPs expressed that the risks associated with vaccinations or nonvaccinations are unknown, and that the long-term risks associated with
vaccinations are similarly unidentified, including for example, linkage
to ailments and diseases.61 Blaisdell and colleagues learned that VHPs
who perceived vaccinations as risky stated that they were fearful of
additives, the permanency of the decision, and that their infants were
too young to process the vaccination.62 These parents also perceived
the risk of contracting a vaccine-preventable disease as low, and based
their perception on low-risk environments, low-severity of disease, and
healthy environments.63 When pressed about what the parents would
do if their child was exposed to a vaccine-preventable disease, they
responded that they would promptly be able to detect, obtain
treatment, or even treat the disease themselves.64 In some cases, they
expressed that the symptoms and treatment of diseases were known
qualities, which suggested they could assign a risk to known attributes.65
Within the VHP focus groups, some decided to either delay
vaccination, change the vaccination schedule, or refuse vaccination
altogether, thus a spectrum of perceived risks was found.66 The quotes
from the VHP participants are particularly illustrative of how VHPs
perceive risk, especially when there are unknowns; a sampling of which
is reproduced here:67
 “We don’t know the long term side effects of some of
these things. A doctor can’t tell me ‘Oh there’s no
long-term side effects’. . . because [they] don’t know.
It stays in your body forever, and there’s all sorts of
things going on that we can’t attribute to any
particular thing. Who’s to say it’s not [vaccination],
because we can’t see the link?”
 “One of the scary things about vaccines is that once
it’s done, it’s done. You can’t undo it. So you know
I have this kid and maybe or maybe not vaccines have
an effect on his progression in his life at this point.”
60

Id. at 480, 485–87.
Id. at 481–83.
62
Id.
63
Id. at 483–84.
64
Id. at 484.
65
Blaisdell, supra note 19, at 484 (“I think that now if you can catch something,
all these dreadful diseases, if you rush to the hospital right away they can probably save
your life. So I’d rather go with that and see if something happens and then go that
way [vaccinate].”).
66
See id. at 485–87.
67
Id. at 483–85.
61
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“We don’t send them to any daycares. I felt like they
weren’t exposed to a lot of different kids all day long,
or for long periods of time without me around
watching them and keeping them safe. It doesn’t
mean they are not gonna get a disease, it also means
that they have a less chance.”
 “I think that now if you catch something, all these
dreadful diseases, if you rush to the hospital right
away they can probably save your life. So I’d rather
go with that and see if something happens then go
that way [vaccinate].”68
Blaisdell and colleagues utilized the ambiguity decision-making
theory not only to categorize the reasoning of the VHPs, but also
suggest that understanding how VHPs assign risk can be used to
educate and address individual concerns.69
Interestingly, the largest group of anti-vaccine advocates turns out
to be upper-middle class white women.70 It is unclear why this group,
specifically, questions the validity and safety of vaccines, but some
hypothesize that they are merely less trusting of medical authorities
generally.71 Another reason could be the luxury of wanting to return
to a more wholesome state when things were simpler—we see this with
food choices, homeopathic treatments, and avoiding the “poisons” in
vaccinations.72
While the Blaisdell study nicely categorizes the responses by VHPs
into risk perceptions based on ambiguity, many of the responses
suggest affect could play a role in risk perception. If VHPs perceive
that a vaccine will harm their child, they will feel “badness” about
making a decision to vaccinate. Or, conversely, a VHP may experience
“goodness” of refusing a vaccine because s/he perceives they have
averted a high-risk situation. This scenario nicely fits into Slovic and
colleagues’ theory that when a subject views the risk as high, they also
view the benefit as low.73
68

Id.
Id. at 479–80.
70
Id.
71
Moser, supra note 55 (“Parents whose children have been exempted from
vaccinations have, unsurprisingly, less trust in a long list of authorities, from health
care professionals to the CDC.”).
72
See, e.g., Rachel Dunlop, 9 Vaccination Myths Busted. With Science!, MAMAMIA (Nov.
12, 2011), http://www.mamamia.com.au/vaccination-myths-busted-by-science-cheatsheet-on-immunisation/ (discussing vaccination myths); see also Renee Shaw Hughner
et al., Who are Organic Food Consumers? A Compilation and Review of Why People Purchase
Organic Food, 6 J. CONSUMER BEHAV. 94, 101–03 (2007).
73
Slovic, Risk Perception and Affect, supra note 27, at 323 (see citation therein).
69
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If the VHPs existed in a vacuum, the discussion might simply turn
to a debate about whether parents are harming their children by
refusing to vaccinate. But, the problem with allowing individuals to
opt-out of vaccinating their children is that it has a ripple effect. To
be effective in group settings, such as school classrooms, the
compliance rate with vaccinations needs to be at a level to achieve the
requisite herd immunity. California, for example, now requires that
children attending preschool and public school be vaccinated absent
a medical contraindication.74 It is possible that consumers also have an
affective response to the term “mandatory.”
An important policy issue is how to educate the VHPs so that they
can appropriately assign risk and make an informed decision. Simply
providing VHPs with the scientific consensus is probably not enough;
otherwise, we would likely not see this problem manifesting, especially
among college-educated women.
Another policy concern is
differentiating for VHPs the existing knowledge about vaccines as
compared to other areas whether medical professionals have had to
backtrack, such as with nutritional recommendations. Part III explores
various options to address this issue.
B. GMOs
Genetically Modified Organisms (GMOs) are the subject of major
public debate.75 Although the term genetically engineered (GE) food
is a better term to describe this sector of the food supply, this article
will use the colloquial term GMO. GMOs, collectively, are foods that
have been altered through the application of biotechnology. GMOs
are a more precise application of genetic engineering compared to
conventional breeding.
Our entire food supply is genetically modified.76 Conventional
breeding utilizes several techniques to obtain desired characteristics.77
74

S.B. 277, 2015–16 Reg. Sess. (Cal. 2015); see also Tara Haelle, California
Vaccination Bill SB 277 Signed By Governor, Becomes Law, FORBES (June 30, 2015, 2:14
PM), http://www.forbes.com/sites/tarahaelle/2015/06/30/california-vaccinationbill-sb-277-signed-by-governor-becomes-law/#6091044a1233.
75
William Saletan, Unhealthy Fixation: The War Against Genetically Modified
Organisms is Full of Fearmongering, Errors, and Fraud. Labeling Them Will Not Make You
Safer, SLATE (July 15, 2015, 5:45 AM), http://www.slate.com/articles/health_and
_science/science/2015/07/are_gmos_safe_yes_the_case_against_them_is_full_of_fra
ud_lies_and_errors.html.
76
Sax & Doran, supra note 22, at 630; cf. Saletan, supra note 75.
77
R. Panda et al., Challenges in Testing Genetically Modified Crops for Potential Increases
in Endogenous Allergen Expression for Safety, 68 ALLERGY: EUR. J. ALLERGY & CLINICAL
IMMUNOLOGY 142, 142 (2013), http://onlinelibrary.wiley.com/doi/10.1111/all.12076
/pdf.
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Conventional tactics such as selective breeding, x-rays, and chemical
mutagenesis are employed to create and select for an “improved”
The genetic modifications using
domestic crop or animal.78
conventional methods, along with seed selection by commercial
breeders, have proved—over hundreds of years—to be safe, and food
created through conventional methods easily enters the marketplace.79
Despite misperceptions of some of the public, organic food is also
genetically modified, but through conventional methods.80 Organic
farmers are growing domesticated crops selected for desired traits.
The term “organic” does not refer to whether the crop has genetic
advantages through selective breeding.81 Put differently, we are not
eating wild-type varieties; we are eating domesticated crops that are
genetically modified.
The technology to create food from GMOs is a precise mechanism
to accomplish what we already do in our food supply.82 Unlike
conventional breeding techniques, genetic engineering techniques
allow for a precise modification to obtain a desired trait. In
conventional breeding techniques, to obtain a desired trait, the seed
may also carry hundreds to thousands of other mutations––most of
which are never characterized.83 In other words, genetic engineering
78

See, e.g., Gregory Conko et al., A Risk-Based Approach to the Regulation of Genetically
Engineered Organisms, 34 NATURE BIOTECHNOLOGY 493, 494 (2016) (internal citations
omitted) (“When plant breeders have exhausted the genetic resources (germ, plasm)
within their crop’s species, they have employed several techniques, such as
mutagenesis and wide-cross hybridization, to introduce new genes or alleles into their
cultivars. By the middle of the past century, X-ray and other mutagens were being
used routinely and at scale to obtain a range of genetic changes, from point mutations
to translocations in interspecific hybrids; the latter allowed pieces of chromosomes
from wild species to integrate or translocate onto crop chromosomes. Mutation
breeding is now routinely accomplished with other sources of ionizing radiation and
with mutagenic chemicals.”).
79
See id. at 494 (“Nevertheless, such ‘non-recombinant DNA transgenic varieties’
(as they might be called) have been introduced safely into commercial cultivation
around the world for more than a half-century without the need for premarket
regulatory approvals.”).
80
See, e.g., David Newland, Sorry Hipsters, That Organic Kale is a Genetically Modified
Food, SMITHSONIAN.COM (Sept. 10, 2014), http://www.smithsonianmag.com/science/
sorry-hipsters-organic-kale-genetically-modified-food-180952656/?no-ist.
81
See
generally
Organic
Agriculture,
U.S.
DEP’T
OF
AGRIC.,
http://www.usda.gov/wps/portal/usda/usdahome?contentidonly=true&contentid=o
rganic-agriculture.html (last updated Jan. 9, 2015) (describing organic agriculture).
82
Steven H. Strauss & Joanna K. Sax, Ending Event-Based Regulation of GMO Crops,
34 NATURE BIOTECHNOLOGY 474, 476 (2016) [hereinafter Strauss & Sax].
83
See Conko et al., supra note 78, at 494 (internal citation omitted) (“Many crops
contain genes crossed in from wild relatives that have no history of safe use and that
may even be known to produce toxins or allergens. In wide-cross hybridization, the
genes or alleles of interest are moved into the crop—along with countless other
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technology allows scientists to obtain desired traits with less genetic
mutations.84
In the 1980s, the Food and Drug Administration (FDA) expressed
concerns about increased expression levels of endogenous toxins or
allergens that may result from genetic engineering techniques.85 This
is because changes to the genetic profile can increase or decrease the
expression of other genes.86 Since then, many dozens of studies have
demonstrated that technology used to create GMO crops does not lead
to the mass destabilization of genome expression that the FDA was
worried about.87
Many decades of research demonstrate that plant genomes are
highly unstable, with many epigenetic events occurring over time.88
Gene expression profiles cannot be captured at any one time, given
the widespread changes.89 Transpositions are often occurring, which
will shake up the genetic sequence.90 Due to the high plasticity of plant
genetic changes of unknown function, including those that potentially could alter the
weediness of the plants or the allergenicity, toxicity or nutritional value of foods
derived from them.”).
84
Cf. Strauss & Sax, supra note 82, at 475.
85
Statement of Policy – Food Derived from New Plant Varieties, Guidance to
Industry for Foods Derived from New Plant Varieties, 57 Fed. Reg. 22,984 (May 29,
1992),
http://www.fda.gov/Food/GuidanceRegulation/GuidanceDocumentsRegulatoryInf
ormation/Biotechnology/ucm096095.htm.
86
Id. (“DNA segments introduced using the new techniques insert semi- randomly
into the chromosome, frequently in tandem multiple copies, and sometimes in more
than one site on the chromosome. Both the number of copies of the gene and its
location in the chromosome can affect its level of expression, as well as the expression
of other genes in the plant.”).
87
Strauss & Sax, supra note 82, at 475 (2016) (citing R.A. Herman & W.D. Price,
Unintended compositional changes in genetically modified (GM) crops: 20 years of research, 61
J. AGRIC. FOOD CHEM. 11695–701 (2013); H.Y. Steiner et al., Editor’s choice: Evaluating
the potential for adverse interactions within genetically engineered breeding stacks, 161 PLANT
PHYSIOLOGY 1587, 1587–94 (2013), https://www.ncbi.nlm.nih.gov/pmc/articles/PM
C3613440/pdf/1587.pdf; A.E. Ricroch, Assessment of GE food safety using ‘-omics’
techniques and long-term animal feeding studies, 30 NATURE BIOTECHNOLOGY 349, 349–54
(2013); J. Schnell et al., A comparative analysis of insertional effects in genetically engineered
plants: considerations for pre-market assessments, 24 TRANSGENIC RES. 1, 1–17 (2015),
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4274372/).
88
Strauss & Sax, supra note 82, at 476 (“These studies show evidence of far greater
structural, epigenetic and gene-expression variation than had been expected, in
general, far exceeding those imparted by genetic engineering (e.g., refs.
11,24,25,26).”).
89
Id. at 476 nn.22 & 24 (“Gene insertion appears to be a small impact by
comparison to the ongoing dynamic variation in gene and genome structure during
evolution and breeding.”).
90
Id. (“Extensive transposition, where genes and promoters are moved
throughout genomes, and normal mutational processes and DNA repair, provide a
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genomes, precise genetic changes, particularly at a single base pair
level, create a risk of the increased expression of toxic or allergenic
proteins that is close to zero.91 Put differently, if the more widespread
changes to plant genomes through conventional breeding does not
increase the expression of toxic of allergenic proteins, then the less
invasive and more precise technology used to create food from GMOs
should not and does not create greater risk in this area.
The public is heavily weighing in on our food supply—calling for
more nutritious food, sustainable farming, and safety. This call for
health, safety, and the environment is manifesting itself through
labeling laws.92 People want to know what they are eating.
The problem with labeling laws—labeling food as GMO, nonGMO, organic, etc.—is that the laws do not tell the consumer about
the health, safety, or environmental friendliness. Decades of research
demonstrate that food from GMOs is as safe as conventional food.93
continual source of potential novelty in the kinds and degrees of modification of gene
expression throughout the genome.”).
91
Id. (“Thus, the risk of unintended expression of endogenous toxic proteins
from genetic engineering is no greater than conventional breeding, and in most cases
far less.”); see also Conko et al., supra note 78, at 493–99.
92
See, e.g., S. Res. 764, 114th Cong. (2016) (enacted) (amending the Agricultural
Marketing Act of 1946, 7 U.S.C. 1621 (2012)); H.R. Res. 1599, 114th Cong. (2016)
(enacted). See also An Act Relating to the Labeling of Food Produced with Genetic
Engineering, VT. STAT. ANN. tit. 9, §§ 3040, 3041 (2014) (effective July 1, 2016); Press
Release, Mike Pompeo, U.S. Congressman, Pompeo Applauds Passage of Safe and
Accurate Food Labeling Act (July 23, 2015), http://pompeo.house.gov/news/
documentsingle.aspx?DocumentID=398519.
93
Chelsea Snell et al., Assessment of the Health Impact of GM Plant Diets in Long-term
and Multigenerational Animal Feeding Trials: A Literature Review, 50 FOOD & CHEMICAL
TOXICOLOGY 1134, 1145 (2012); Pamela Ronald, Plant Genetics, Sustainable Agriculture
and Global Food Security, 188 GENETICS 11, 12 (2011); Press Release, American
Association for the Advancement of Science, Statement by the AAAS Board of
Directors on Labeling of Genetically Modified Foods (Oct. 20, 2012),
http://www.aaas.org/sites/default/files/migrate/uploads/AAAS_GM_statement.pdf
[hereinafter Statement by AAAS]; Yan Song et al., Immunotoxicological Evaluation of Corn
Genetically Modified with Bacillus thuringiensis Cry1Ah Gene by a 30-day Feeding Study in
BALB/c Mice, 9 PLOS ONE 1, 10 (Feb. 10, 2014), http://www.plosone.org/article/info
%3Adoi%2F10.1371%2Fjournal.pone.0078566; Yanfang Yuan et al., Effects of
Genetically Modified T2A-1 Rice on the GI Health of Rats After 90-day Supplement, 3 SCI. REP.
1, 6–7 (June 11, 2013), http://www.nature.com/srep/2013/130611/srep01962/pdf/
srep01962.pdf; Xueming Tang et al., A 90-Day Dietary Toxicity Study of Genetically
Modified Rice T1C-1 Expressing Cry1C Protein in Sprague Dawley Rats, 7 PLOS ONE 1, 6
(Dec. 27, 2012), http://www.plosone.org/article/info%3Adoi%2F10.1371%2F
journal.pone.0052507. See also Philip D. Brune et al., Safety of GM Crops: Compositional
Analysis, 1 J. AGRIC. & FOOD CHEMISTRY 8243, 8245 (2013); William D. Price & Lynne
Underhill, Application of Laws, Policies, and Guidance from the United States and Canada to
the Regulation of Food and Feed Derived from Genetically Modified Crops: Interpretation of
Composition Data, 1 J. AGRIC. FOOD & CHEMISTRY 8349, 8353 (2013); Declan Butler,
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Consumers might be surprised to learn that food labeled “organic”
does not have a higher safety profile than other types of food and, in
some cases, it actually has a lower safety rating.94 This is because
organic farmers use manure as fertilizer, which, when mishandled,
creates major safety concerns. Consumers are worried about exposure
to pesticides and herbicides, although scientific studies are clear that
low-level exposure to the most commonly used pesticides and
herbicides creates no risk to human health.95 The environmental
concerns are more difficult to address not because something is GMO,
non-GMO or organic, but because farming is inherently non-ecofriendly.96 The sustainability component is much more nuanced than
labeling can tell a consumer.
To understand consumer decision-making, a survey aimed at
consumer associations of health, safety, and environmental
friendliness with various labels and types of food was conducted.97
Subjects were asked to rank how healthy, safe, and environmentallyfriendly various food products with the labels “organic,” “natural,” “low
fat or fat free,” “non-GMO” and “GMO” were compared to each
other.98 The results showed that respondents found all labels to be
significantly healthier, safer, and environmentally friendly compared
to the label “GMO.”99 In other words, the subjects found the label
“GMO” to be associated with less healthy, less safe, and less
environmentally friendly food products compared to other labels.100
The results of this study provide a number of interesting

Hyped GM Maize Study Faces Growing Scrutiny, NATURE INT’L WKLY. J. SCI. (Oct. 10, 2012),
http://www.nature.com/news/hyped-gm-maize-study-faces-growing-scrutiny-1.11566
(rejecting paper that found adverse health events in rats fed GM corn).
94
Mischa Popoff et al., Organics versus GMO: Why the debate?, GENETIC LITERACY
PROJECT (Oct. 15, 2013), http://www.geneticliteracyproject.org/2013/10/15/
organics-versus-gmo-why-the-debate/; A. Mukherjee et al., Preharvest Evaluation of
Coliforms, Escherichia coli, Salmonella, and Escherichia coli O157:H7 in Organic and
Conventional Produce Grown by Minnesota Farmers, 67 J. FOOD PROTECTION 894, 894–900
(2004).
95
See,
e.g.,
Food
and
Pesticides,
ENVTL.
PROTECTION
AGENCY,
https://www.epa.gov/safepestcontrol/food-and-pesticides (last updated Mar. 15,
2016); G.M. Williams et al., Safety Evaluation and Risk Assessment of the Herbicide Roundup
and Its Active Ingredient, Glyphosate, for Humans, 31 REG. TOXICOLOGY & PHARMACOLOGY
117, 117 (2000) (“Roundup herbicide does not pose a health risk to humans.”).
96
See Henry I. Miller, Why Organic Isn’t ‘Sustainable’, FORBES (Nov. 19, 2014),
http://www.forbes.com/sites/henrymiller/2014/11/19/why-organic-isntsustainable/2/#9166d235aed9.
97
Sax & Doran, supra note 22, at 630–38.
98
Id. at 633.
99
Id. at 634–35.
100
Id.
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observations. First, the label “natural” has no regulatory definition.101
Despite this, respondents associated the label “natural” with health,
safety, and environmental friendliness.102 Second, the scientific
consensus is that food from GMOs is as safe as conventional food. The
results demonstrate a consumer disconnect with scientific consensus,
and suggest that it is important to undertake studies to understand
why. Finally, the results suggest that additional studies are needed to
understand why consumers inappropriately assign risk to food labeled
as GMO.103
Affect and ambiguity might help explain consumer perceptions
of food created from GMOs. If consumers perceive food created from
GMOs as less safe, less healthy or less environmentally friendly, then
they might experience a feeling of “badness” when purchasing or
eating this food.104 Conversely, consumers may experience “goodness”
when buying food that they believe is safe, healthy, and
environmentally friendly, such as organic food. In other words,
consumers will want to make decisions that reproduce pleasant
feelings, and consumers may be more likely to buy food that satisfies
their affective tendencies.105 Similarly, when consumers feel as though
they do not understand GMO technology, they will be unable to assign
risk to food created by this technology. Additionally, consumers may
have trouble evaluating information in the face of conflicting
information from apparently credible sources. In the end, consumers
might rather buy conventional food because they can assign a risk to
that food, than buy food from GMOs where they perceive that they
cannot assign a risk.
Policymakers need to address the multitude of problems facing
our food supply. Scientific advances have often been the solution to
problems. From a scientific perspective, genetic engineering provides
an important avenue to solve food supply issues and address
environmental concerns. It would be interesting to determine the
outcome if consumers were told that conventional food contains
hundreds to thousands of unknown and uncharacterized mutations
(which is true), and whether they would still feel as confident in
choosing non-GMO over GMO. These types of issues will be explored
101

Id. at 635.
Id. at 634–35.
103
Sax & Doran, supra note 22, at 634–35.
104
Id.
105
See Slovic, Risk Perception and Affect, supra note 27, at 322 (“Many theorists have
given affect a direct and primary role in motivating behavior. Pleasant feelings
motivate actions that people anticipate will reproduce those feelings. Unpleasant
feelings motivate actions that people anticipate will avoid those feelings.”).
102
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in Part III.
C. rbST
Recombinant bovine somatotrophin (rbST) is the injection of a
naturally occurring bovine growth hormone, to increase milk
production in cows.106 Two areas of scientific research converged to
establish this technique. First, recombinant DNA (rDNA) technology
allows scientists to create genes in a laboratory and then produce the
proteins therefrom in a bacteria culture.107 The produced protein is
then purified and the result is the man-made version of an otherwise
naturally occurring protein. Second, research demonstrated that
injecting bovine growth hormone into cows increased their milk
production.108 This bovine growth hormone (bGH or bST) is naturally
produced by the pituitary gland.109 By combining these two areas of
research, scientists demonstrated that bGH—also referred to as bovine
somatotropin or Sometribove––created through rDNA could be
injected into dairy cows to increase milk production.110
The
111
recombinant forms of the bGH are referred to as rbGH or rbST.
Growth hormones, while naturally occurring in mammals, are
tightly regulated within a naturally occurring system.112 The concern
expressed about rbST is whether it has adverse health events in
106

Lorna Aldrich & Noel Blisard, Consumer Acceptance of Biotechnology Lessons from
the rbST Experience, 747–01 CURRENT ISSUES IN ECON. OF FOOD MKTS. 1, 1 (1998),
https://naldc.nal.usda.gov/download/34230/PDF (“[L]aboratory-produced rbST,
when injected into cows, increases their milk production.”).
107
Anthony J.F. Griffiths, Recombinant DNA Technology, ENCYCLOPEDIA BRITANNICA,
http://www.britannica.com/science/recombinant-DNA-technology (last updated
Apr. 8, 2016).
108
Bovine Somatotropin, ANIMAL & PLANT HEALTH INSPECTION SERVS. (May 2003),
https://www.aphis.usda.gov/animal_health/nahms/dairy/downloads/dairy02/Dairy
02_is_BST.pdf (“Repeated studies have demonstrated that administering bST to
lactating dairy cattle significantly increases milk production.”).
109
See Aldrich & Blisard, supra note 106, at 1 (“BST is a bovine growth hormone
that occurs naturally in cows[.]”); see also Is Milk from rbGH-Injected Cows Safe? Why Isn\’t
It Labeled?, UCBIOTECH.ORG, http://ucbiotech.org/answer.php?question=37 (last
updated Feb. 16, 2012) [hereinafter Is Milk from rbGH-Injected Cows Safe?] (“bGH,
produced in the pituitary glands of dairy cows, is a naturally occurring protein
hormone in milk, which stimulates the liver to produce insulin-like growth factor-I
(IGF-I).”).
110
Report on the Food and Drug Administration’s Review of the Safety of Recombinant
Bovine
Somatotropin,
U.S.
FOOD
AND
DRUG
ADMIN.,
http://www.fda.gov/AnimalVeterinary/SafetyHealth/ProductSafetyInformation/uc
m130321.htm (last updated July 28, 2014) [hereinafter FDA Report on rBST].
111
See, e.g., Is Milk from rbGH-Injected Cows Safe?, supra note 109.
112
See, e.g., Nathalie Girard et al., Differential in vivo Regulation of the Pituitary Growth
Hormone-Releasing Hormone (GHRH) receptor by GHRH in Young and Aged Rats, 140
ENDOCRINOLOGY 2836, 2836 (1999).
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humans and cows.113 Through extensive FDA evaluation and decades
of research, it has been shown that “bGH is biologically inactive in
humans even if injected, rbGH is orally inactive, and bGH and rbGH
are biologically indistinguishable.”114
In recent years, consumers have been pulled into a medley of
debates and concerns among manufacturers. Some manufacturers are
utilizing an “rbST-free” label.115 Monsanto, the big agriculture giant,
has sued over this type of labeling—presumably because the label
indicates that something is rbST-free because there are health
concerns to avoid.116 Attorneys for Monsanto argued that the FDA
recommended that these types of labels be provided in the proper
context; for example, “no significant difference has been shown
between milk derived from (hormone)-treated and non-(hormone)treated cows.”117 If, however, a consumer wants to find a negative take
on rbST, they can be led to Organic Valley’s website to obtain
information about the use of rbST.118
The labeling debate is indicative of the array of information that
consumers receive. If consumers want to learn about the contours of
rbST, they will find a broad array of information—some correct, some
113

See Is Milk from rbGH-Injected Cows Safe?, supra note 109.
FDA Report on rBST, supra note 110.
115
See, e.g., ORGANIC VALLEY, https://www.organicvalley.coop/why-organicvalley/5-reasons-eat-organic/because-our-cows-and-kids-should-grow-their-own-pace/
(last visited Jan. 12, 2017) (citing On the Offense, GRACE COMM. FOUND.,
http://www.sustainabletable.org/797/rbgh (last visited Nov. 23, 2016)). But see
Background on the Public Hearing on the Labeling of Food Made from the AquAdvantage
Salmon, U.S. FOOD & DRUG ADMIN., http://www.fda.gov/Food/GuidanceRegulation/
GuidanceDocumentsRegulatoryInformation/LabelingNutrition/ucm222608.htm
(last updated Nov. 19, 2015) (internal citation omitted) (“For example, recombinant
Bovine Somatotropin (“rBST”) is a synthetic growth hormone that increases milk
production in dairy cows. Because FDA found that there was no material difference
between milk from rBST-treated cows and milk from non-rBST-treated cows, FDA did
not have the authority to require additional labeling of milk from rBST-treated
cows.”).
116
Susan Q. Stranahan, Monsanto vs. the Milkman, MOTHER JONES (Jan/Feb 2004),
http://www.motherjones.com/politics/2004/01/monsanto-vs-milkman (“Oakhurst’s
labels, contends Monsanto, might cause consumers to question the drug’s safety, even
though the FDA has found that milk from cows injected with rBGH is the same as
regular milk and that the hormone poses no human health risks.”).
117
Matt Wickenheiser, Oakhurst Sued by Monsanto Over Milk Advertising: Monsanto
Objects to the Dairy’s Public Stance Against Using Hormones, PORTLAND PRESS HERALD, July
8, 2003, at 1A; see also Bovine Somatotropin, WIKIPEDIA, https://en.wikipedia.org/wiki/
Bovine_somatotropin (last visited May 25, 2016).
118
Recombinant Bovine Growth Hormone (rBGH): What is it?, ORGANIC VALLEY,
http://organicvalley.custhelp.com/app/answers/detail/a_id/152/kw/rbst/session/
L3RpbWUvMTQ2NDE5NjQzNS9zaWQvSktQbHVvUm0%3D (last visited July 21,
2016) (providing reasons why rBGH is bad for cows, people, and farmers).
114
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wrong, and some contradictory. Consumers might learn that some
data indicates that cows treated with rbST also have elevated levels of
insulin-like growth factor-1 (IGF-1), which can be absorbed in a human
gut.119 The increased exposure of IGF-1 in humans raises concerns
about increased levels of cancer. Thus, the association of rbST and
IGF-1 continues to be promoted as a possible adverse consequence for
people who drink milk from cows treated with rbST.120 Studies show
that milk consumption, whether from cows treated with rbST or not,
appears to be correlated with increased levels of IGF-1, but no scientific
consensus exists regarding causation.121
The Center for Food Safety, an apparent activist group, has
portions of its website dedicated to rbST.122 The Center for Food Safety
uses a child drinking a glass of milk to not-so-quietly hint about rbST
concerns.123 The Center for Food Safety alleges that cows treated with
rbST may also then need antibiotic treatment for the side effects,
which subsequently create residues in milk that “can cause allergic
reactions in sensitive individuals and contribute to the growth of
antibiotic resistant bacteria, further undermining the efficacy of some
antibiotics in fighting human infections.”124
While the Center for Food Safety’s representation has a hint of
truth, the discussion is more nuanced than how it is presented. A
major area of scientific concern is with the health of the cows.125
119

FDA Report on rBST, supra note 110.
ORGANIC
VALLEY,
https://www.organicvalley.coop/why-organic-valley/5reasons-eat-organic/because-our-cows-and-kids-should-grow-their-own-pace/
(last
visited Jan. 12, 2017) (click on “Read the Report” under the statement: “Artificial
hormone (rBGH / rBST) injections in cows: inhumane and unnecessary”).
121
Recombinant
Bovine
Growth
Hormone,
AM.
CANCER
SOC’Y,
http://www.cancer.org/cancer/cancercauses/othercarcinogens/athome/recombin
ant-bovine-growth-hormone (last updated Sept. 10, 2014) (“The evidence for potential
harm to humans is inconclusive.”); see also FDA Report on rBST, supra note 110 (“It
bears repeating that the assumptions that milk levels of IGF-I are increased following
treatment with rbGH and that biologically active IGF-I is absorbed into the body are
not supported by the main body of science. Careful analysis of the published literature
fails to provide compelling evidence that milk from rbGH-treated cows contains
increased levels of IGF-1 compared to milk from untreated cows. Despite recent
studies that demonstrate that milk proteins protect IGF-I from digestion, the vast
majority of the published work indicates that very little IGF-I is absorbed following
ingestion.”).
122
About rbGH, CTR. FOR FOOD SAFETY, http://www.centerforfoodsafety.org/issues/
1044/rbgh/about-rbgh (last visited May 25, 2016).
123
Id.
124
Id.
125
I.R. Dohoo et al., A Meta-Analysis Review of the effect of Recombinant Bovine
Somatotropin, 2. Effects on animal Health, Reproductive Performance and Culling, 67 THE
CANADIAN J. OF VETERINARY RES. 252, 253 (2003).
120
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Treatment with rbST is associated with mastitis, which is an infection
of the breast tissue.126 Treatment of mastitis includes the use of
antibiotics.127
The array of information regarding rbST creates challenges for
consumers to appropriately assign risk to this application of
biotechnology. If consumers perceive that treatment of cows with rbST
causes cancer in humans, then consumers will assign a high risk.
Likewise, if consumers perceive that children will be harmed by
drinking milk from cows treated with rbST, then they will experience
“badness” with an associated decision. The varying information on the
Internet about rbST creates issues for consumer decision-making
because consumers may not be able to appropriately assign risk.
The rbST and GMO debates underscore the need for a robust
discussion about how we use science to improve our food supply and
agriculture techniques. If consumers have concerns, they should be
addressed. It is important, however, that the concerns and assignment
of risk are based on accurate information. If information is lacking,
studies in these areas should be initiated. In Part III, below, this article
proposes studies aimed at understanding if and how consumers are
responding to conflicting information on the Internet.
D. Fluoridated Water
Touted as one of the greatest public health achievements in the
20th Century, fluoridated water significantly decreases cavities, tooth
decay and tooth loss in children and adults.128 Fluoridated water refers
to the addition of fluoride to the public water supply. Tooth decay is
a major public health problem due to the medical concern that tooth
decay impairs eating, but also because of the cosmetic effect on societal
acceptance.129 Overall, the cost to fluoridate water is much less

126

Id. at 252 (“Recombinant bovine somatotropin was found to increase the risk of
clinical mastitis by approximately 25% during the treatment period but there was
insufficient data to draw firm conclusions about the effects of the drug on the
prevalence of subclinical intra-mammary infections.”).
127
Walter L. Hurley, Mastitis Case Studies Mastitis Treatment and Control,
http://ansci.illinois.edu/static/ansc438/Mastitis/control.html (last visited May 24,
2016) (“Typically when clinical mastitis is detected, the cow is milked out and then
given an intramammary infusion of antibiotic, ie. infused directly into the infected
gland.”).
128
Fluoridation
Basics,
CTR.
FOR
DISEASE
CONTROL,
http://www.cdc.gov/fluoridation/basics/ (last updated July 28, 2015) [hereinafter
CDC, Fluoridation Basics].
129
Id.; see also Water Fluoridation, WIKIPEDIA, https://en.wikipedia.org/wiki/Water_
fluoridation (last visited May 25, 2016).
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expensive than the treatment for cavities.130
The only known adverse effect associated with fluoridated water
is dental fluorosis, which is a mild condition, usually found on
children’s teeth that alters the appearance.131 Dental fluorosis is not a
public health concern and can be tempered by monitoring fluoride
intake, including toothpaste.132 Over exposure to fluoride is associated
with minor adverse health effects, which means that fluoridation is
tightly monitored and adjusted.133 Decades of research demonstrate
that fluoride levels in the 0.7 milligrams of fluoride per liter of water
range have the desired public health benefit and have a low risk of
causing dental fluorosis. 134
The Center for Disease Control, the American Dental Association
and the American Medical Association all support fluoridated water
programs based on the widespread dental health benefits. Economic
analysis found that for “every $1 invested in this preventative measure
yields approximately $38 savings in dental treatment costs.”135
Not immune from controversy, opponents to fluoridated water
challenge the science and efficacy. Some communities in the US are
moving towards or are enacting non-fluoridation programs. In
Portland, Oregon, for example, voters defeated a plan to add fluoride
to the public water supply.136
Similar to the above examples, an Internet search reveals a wide
array of information. Consumers can find allegations that fluoridation
is linked to AIDS.137 This does not make sense given that AIDS is caused
130

CDC, Fluoridation Basics, supra note 128.
Fluoridation Safety, CTR. FOR DISEASE CONTROL, http://www.cdc.gov/fluoridation
/safety/index.htm (last updated May 13, 2015) (“Dental fluorosis is a change in the
appearance of the tooth’s enamel. These changes can vary from barely noticeable
white spots in mild forms to staining and pitting in the more severe forms.”).
132
FAQs for Dental Fluorosis, CTR. FOR DISEASE CONTROL, http://www.cdc.gov/
fluoridation/safety/dental_fluorosis.htm#a9 (last updated Aug. 31, 2015).
133
Id.
134
Community Water Fluoridation, CTR. FOR DISEASE CONTROL, http://www.cdc.gov/
fluoridation/faqs/ (last updated July 28, 2015).
135
Cost Savings of Community Water Fluoridation, CTR. FOR DISEASE CONTROL,
https://www.cdc.gov/fluoridation/factsheets/cost.htm (last updated July 10, 2013).
136
Douglas Main, Facts About Fluoridation, LIVESCIENCE (Apr. 30, 2015),
http://www.livescience.com/37123-fluoridation.html (“For the fourth time since
1956, voters in Portland defeated a plan in 2012 to add fluoride to the public water
supply.”).
137
See, e.g., Water Fluoridation Controversy, WIKIPEDIA, https://en.wikipedia.org/wiki
/Water_fluoridation_controversy (last visited May 25, 2016) (“Antifluoridationist
literature links fluoride exposure to a wide variety of effects, including AIDS, allergy,
Alzheimer’s disease, arthritis, cancer, and low IQ, along with diseases of the
gastrointestinal tract, kidney, pineal gland, and thyroid.”).
131
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by a virus and fluoride is an element. Moreover, a person cannot
contract HIV/AIDS by drinking water. Action groups against
fluoridated water programs also exist online. Fluoride Action
Network, for example, provides three main reasons to oppose
fluoridated water programs: (1) outdated mass medication; (2)
unnecessary and ineffective; and (3) unsafe.138 It is clear from
reviewing the Fluoride Action Network website that fear is the main
motivator to influence opposition to fluoridated water. This website
strongly suggests that the government is administering drugs to people
against their will. Additionally, according to this group, there is no
benefit to fluoride and the risk of developing disease is high.139
Given that consumers receive a wide array of information
regarding the safety and efficacy of fluoridated water programs, it is
not surprising that consumers may not appropriately assign risk to
these programs. If, for example, consumers perceive that there might
be long-term deleterious consequences from fluoridated water, they
will inappropriately assign risk to community fluoridation programs.
Similarly, if consumers perceive the benefit as low, they might assign a
high risk to these programs. In addition, consumers may associate
“goodness” or “badness” with decisions to reject or embrace
widespread fluoridation programs.
E. Embryonic Stem Cell Research
Unlike the above examples, this area of biotechnology raises a
different issue—that of research funding. The areas above are already
in the implementation and application stages. While some clinical
trials are in progress, embryonic stem cell research is in a more infant
stage and will require major sources of funding to capture its full
potential. In this controversial area of research, consumers were
explicitly called on to be part of the conversation and assist in the
decision as to whether the federal government should fund embryonic
stem cell research.
By way of background, in the 1990s, scientists began
hypothesizing that they could harness the plasticity of embryonic stem
cells to treat disease.140 Embryonic stem cells are early progenitor cells

138

Water Fluoridation, FLUORIDE ALERT, http://fluoridealert.org/issues/water/
(last visited Oct. 31, 2016).
139
See id.
140
Stem Cell Information: Stem Cell Basics, NAT’L INSTS. OF HEALTH,
https://stemcells.nih.gov/info/basics/1.htm (last visited Dec. 31, 2016) [hereinafter
NIH STEM CELL INFORMATION].
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that have the ability to turn into many different cell types.141 Cell
signals are given to these early progenitor cells to tell them to become
muscle, organ, neural or skeletal cells.142 Since many human ailments
are characterized by a loss of function of particular cells, the idea was
that the diseased cells could be replaced by non-diseased cells.143 Put
differently, if an individual’s pancreas, for example, has problems with
insulin producing cells, the patient could be treated with a stem cell
therapy to replace the diseased pancreatic cells with healthy pancreatic
cells. This similar, hypothetical approach could be used to treat major
ailments such as Parkinson’s disease, Alzheimer’s Disease, muscular
dystrophy, and others.144
Controversy ensued regarding the starting material for embryonic
stem cell research, which is fertilized eggs—created in vitro.145
Opponents to embryonic stem cell research claimed that the fertilized
eggs had the potential for human life, thus this type of research was
unethical.146 Proponents of embryonic stem cell research looked at the
fertilized eggs as cells and also promoted the potential to treat
disease.147 Some consumers may sit in the middle of this debate—that
is, they may not personally have a moral objection, but they may be
sympathetic to others who do. Thus, while a large part of the debate
has value-based or religious undertones, some portion of the debate is
likely more nuanced than any particular value-based belief.
The debate about whether the federal government should fund
embryonic stem cell research came to a head in 2001 under President
George W. Bush.148 To address this topic, President Bush relied heavily
on the Presidential Commission for Bioethics.149 This panel advises the
President on bioethical issues.150 Leon Kass, the Chair of the
Commission, took center stage during this debate for his views against

141

Id.
Id.
143
Joanna K. Sax, The States “Race” with the Federal Government, 15 ANNALS OF HEALTH
L. 1, 8 (2006) [hereinafter Sax, The States “Race” with the Federal Government].
144
Id.
145
Id. at 9 (citing Allen M. Spiegel & Gerald D. Fischbach, NIH Statement Before
Senate Appropriations Subcommittee, NAT’L INSTS. OF HEALTH (Apr. 26, 2000),
https://stemcells.nih.gov/policy/statements/State.htm).
146
Joanna K. Sax, The Separation of Politics and Science, 7 STAN. J.L. SCI. & POL’Y 10,
16 (2014) [hereinafter Sax, The Separation of Politics and Science].
147
Id.
148
Sax, The States “Race” with the Federal Government, supra note 143, at 15.
149
Id. at 16.
150
About the Commission, PRESIDENTIAL COMMISSION FOR THE STUDY OF BIOETHICAL
ISSUES, http://bioethics.gov/about (last visited May 25, 2016).
142
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the funding of embryonic stem cell research.151 Elizabeth Blackburn,
who was not reappointed to the Presidential Commission for Bioethics
during this time, charged the administration with stacking the
Commission with members who aligned with Leon Kass.152 It was a
political debate.
During this time, the issue of whether to provide federal funding
to research embryonic stem cells was heavily publicized and divisive,
with a lot of press in both mainstream newspapers as well as in scientific
journals.153 In many ways, the issue was raised as a moral issue to which
some politicians wanted constituent feedback. As a representative
democracy, this should seem copasetic with our political process.
Given the highly publicized and politicized nature of the issue of
federal funding for embryonic stem cell research, one study analyzed
the type of information provided to the public regarding embryonic
stem cell research.154 A major contention during this time was whether
scientists could use adult stem cells to achieve the same results as
embryonic stem cells and thus avoid needing to use the controversial
starting material.155 Scientists contended that they could not make this
determination unless and until experiments on both adult and
embryonic stem cells were conducted.156 Some articles in mainstream
newspapers, however, reported that adult stem cells might provide
equivalent starting material as embryonic stem cells.157 This reporting
occurred at different frequencies in different newspapers, but
nevertheless, the information was conveyed to the public.
The reporting of different information, either that adult stem
cells are not equal to embryonic stem cells, or that adult stem cells
might be equal to embryonic stem cells, creates ambiguity. How is a
typical consumer going to weigh that information? Those with a moral
opposition to embryonic stem cell research might perceive the
information differently than those without a moral opposition. That
is, a person may not be personally opposed to the research, but s/he
may be sympathetic to those who are. If people perceive that a
workable compromise exists, i.e., only performing research on adult
stem cells since they are likely to provide the same information, then
they will make a decision accordingly. Put differently, even those
151
152
153
154
155
156
157

Sax, The States “Race” with the Federal Government, supra note 143, at 17.
Id.
See, e.g., Sax, The Separation of Politics and Science, supra note 146, at 8–10.
Id. at 7–14.
Id. at 8–9.
Id. at 9.
Id. at 12.

SAX (DO NOT DELETE)

462

2/16/2017 2:44 PM

SETON HALL LAW REVIEW

[Vol. 47:433

without a moral opposition to embryonic stem cell research might be
impartial to a decision not to fund embryonic stem cell research given
information that a different starting material might give the same
results.
Similarly, affect can impact how consumers view funding of
controversial research. Consumers, for example, might experience
“badness” at the thought of funding embryonic stem cell research.
Whereas other consumers might experience “goodness” at the thought
of the decision to support research that has the potential to treat
debilitating disease(s).
In 2001, President Bush signed an executive order that placed a
practical ban on the funding of embryonic stem cell research.158 In
2009, with a leadership change, President Obama changed course and
allowed federal funding for the creation and experimentation on new
stem cell lines.159
As articulated elsewhere, changes in funding that appear to be
dependent on the administration in charge creates major issues for
scientific inquiry and innovation.160 Putting aside the issues with
funding, this example has similarities with the other biotechnology
examples discussed above. Here, the consumers are asked to make
decisions when there may be incomplete, or even incorrect,
information provided—thus incorporating ambiguity. On top of that,
controversial research may incorporate feelings of goodness or
badness with a decision.
By way of more explicit analogy, the discussion regarding
vaccinations (supra Part II.A) has many similarities to the issues with
funding embryonic stem cell research. First, consumers can search for
and obtain a wide amount of information about either issue on the
Internet. For example, an Internet search might provide misinformation that vaccines cause autism and embryonic stem cell
research is the same thing as an abortion.161 Conversely, an Internet
158

Sax, The States “Race” with the Federal Government, supra note 143, at 15.
Removing Barriers to Responsible Scientific Research Involving Human Stem
Cells, 74 Fed. Reg. 10,667 (Mar. 11, 2009).
160
Sax, The Separation of Politics and Science, supra note 146, at 11–14.
161
Arjun Walia, 22 Medical Studies that Show Vaccines Can Cause Autism, ACTIVIST POST
(Sept. 12, 2013), http://www.activistpost.com/2013/09/22-medical-studies-that-showvaccines.html; Stem Cell Research, SOC’Y FOR THE PROTECTION OF UNBORN CHILD.,
https://www.spuc.org.uk/abortion/embryo-abuse/stem-cell-research (last visited May
24, 2016). But see Vaccines Do Not Cause Autism, CTR. FOR DISEASE CONTROL,
http://www.cdc.gov/vaccinesafety/concerns/autism.html (last updated Nov. 23,
2015); Myths and Misconceptions about Stem Cell Research, CAL. INST. FOR REGENERATIVE
MED., https://www.cirm.ca.gov/patients/myths-and-misconceptions-about-stem-cellresearch (last visited May 24, 2016) (“Embryonic stem cells only come from four
159
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search might provide information that vaccines save lives and that
embryonic stem cell research will be a key to treating individuals with
Alzheimer’s Disease.162 Consumers in both of these situations will be
evaluating inconsistent and even contradictory information, which
makes it difficult to assign risk to a particular outcome. Similarly, given
the emotionally laden undertone of these controversial areas,
consumers may experience “goodness” or “badness” with any
particular decision.
Widespread applications of biotechnology do not have the ability
to satiate all individual concerns and preferences. In other words,
fluoridated water programs cannot indicate which homes would
support the programs versus those which would not, because the
public water supply is supplied to each home. Vaccination programs
require requisite levels of herd immunity to be effective. Embryonic
stem cell research is either funded or not. The issue then becomes:
how do policymakers not only separate the wheat from the chaff, but
also provide information to consumers so that they can appropriately
assign risk to new applications of biotechnology? This article turns to
this issue in Part III.
III. CONSUMER DECISION-MAKING AND POLICY
Understanding consumer decision-making is important when
drafting and implementing policies. Research in decision-making
informs us that consumers may not appropriately assign risk to an
outcome when there are unknowns. In addition, consumers tend to
be more sensitive to information about possible risks than to
information about potential benefits.163 Studies show that consumers
are skeptical of information provided by pharmaceutical companies
(vaccines, rbST, and fluoridated water), agriculture companies
(GMOs), and often even scientists (embryonic stem cell research).164
to five day old blastocysts or younger embryos.”).
162
See, e.g., Stem Cell Research, ALZHEIMER’S SOC’Y, https://www.alzheimers.org.uk/
site/scripts/documents_info.php?documentID=1039 (last updated August 2012).
163
Montserrat Costa-Font & Jose M. Gil, Does Expert Trust and Factual Knowledge
Shape Individual’s Perception of Science?, 36 INT’L J. CONSUMER STUD. 668, 670 (2012).
164
See, e.g., Mark Kessel, Restoring the Pharmaceutical Industry’s Reputation, 32 NATURE
BIOTECHNOLOGY 983, 983 (2014); Maria Altman, Monsanto Appeals Directly to Consumers
in New Ad Campaign, ST. LOUIS PUBLIC RADIO (Nov. 5, 2014),
http://news.stlpublicradio.org/post/monsanto-appeals-directly-consumers-new-adcampaign; Michael McNichol & Zubin Master, Ethical and Scientific Issues Towards the
Successful Translation of Stem Cell Research, BIOETHICS TODAY (Jan. 27, 2014),
http://www.amc.edu/BioethicsBlog/post.cfm/ethical-and-scientific-issues-towardsthe-successful-translation-of-stem-cell-research (“Several social science studies have
shown that patients and the general public trust research done in the public sphere
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On top of this, information regarding technology is imperfect due to
degrees of scientific uncertainty.165 Utilizing communication tactics to
explain the unknowns or to allow information to be less ambiguous
may assist consumers in assigning risk to a particular decision.
Recent scholarship in this area suggests that providing
information to consumers in a manner consistent with decisionmaking theories may assist consumers in assigning risk.166 In a recent
study, Costa-Font and Gil made a number of interesting observations.167
Understanding the science, for example, was associated with a lower
perception of risk. Conversely, a lack of understanding of the
underlying science was associated with higher perceptions of risk.168
This supports the idea that consumers perceive risks as high when
there is either not enough information or the information is
ambiguous.169 Perhaps not surprisingly, Costa-Font and Gil also found
that trust in the expert conveying the information was important to
consumers.170
It might seem easy enough to say that trusted experts should
provide the scientific information and that this will lead consumers to
be in a better position to assign risk. Scientists, however, are not
classically trained to translate their discoveries to the general public.171
The problem with this approach is that not only is it not working but
there are forces that actively oppose it. Marketing professionals, for
example, frequently exploit the nuances of consumer decisionmaking.172 The organic food industry, for example, may actively use
(e.g., publically funded universities and colleges), and are less trustworthy of research
performed in private and commercial institutions e.g., pharmaceutical or biotech
industry. While these same studies also indicate that the public is more than willing to
participate in stem cell research by donating tissues, some still don’t like the idea of a
company making profit and the volunteers not seeing any direct benefit from their
participation in research.”).
165
Costa-Font & Gil, supra note 163, at 670.
166
Id. at 673.
167
Id.
168
Id.
169
Id.
170
Id. at 675.
171
See Center for Public Engagement with Science & Technology, AM. ASS’N FOR THE
ADVANCEMENT OF SCI., http://www.aaas.org/pes/communicatingscience (last updated
Nov. 3, 2016) [hereinafter AAAS].
172
See Slovic, What’s Fear Got to Do with It?, supra note 36, at 983 (“There are two
important ways that experiential thinking misguides us. One results from the
deliberate manipulation of our affective reactions by those who wish to control our
behaviors. (Advertising and marketing exemplify this manipulation). The other
results from the natural limitations of the experiential system and the existence of
stimuli in our environment that are simply not amenable to valid affective
representation.”).
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affect and ambiguity to scare consumers away from food produced
from GMOs. Put differently, the organic food industry has an
economic interest to entice consumers to buy organic food and not to
buy food from GMOs. By making consumers feel “goodness” about
organic food and “badness” about food from GMOs, the organic
industry can exploit consumer decision-making.
A recent study by Hughner and colleagues analyzed which types
of individuals are organic food consumers.173 In surveying several
studies, they identified certain demographics that stand out: organic
food consumers tend to be female, have children, and are older,
though these characteristics are not mutually exclusive of each other.174
Research also suggested that organic food consumers see their
preference associated with a “way of life” and with an ideology.175
Hughner and colleagues articulated nine themes associated with
consumer motivations and six themes associated with consumer
deterrents when deciding whether to purchase organic food.176 The
motivations included: (1) healthier; (2) tastes better; (3)
environmental concern; (4) concern over food safety; (5) concern
over animal welfare; (6) supports local economy and sustain
traditional cooking; and (7-9) wholesome, reminiscent of the past, and
fashionable.177 Deterrents included: (1) high prices; (2) lack of
availability; (3) skepticism of certification boards and labels; (4)
insufficient marketing; (5) satisfaction with current food source; and
(6) cosmetic defects.178
A recent study showed that survey participants perceive that
organic farmers care more about health, safety, and environmental
friendliness compared to conventional or GMO farmers.179 Likewise,
participants also perceive that farmers who grow GMO crops care more
about efficiency (and less about health, safety, and the environment)
compared to organic farmers.180 This perception is unlikely to be
resolved by statements or advertisements by Monsanto (a major
supplier of genetically engineered seeds), especially given consumer
mistrust of some big corporations.181 Interestingly, it may be that largescale industrial farms are more environmentally friendly given that
173
174
175
176
177
178
179
180
181

Hughner et al., supra note 72, at 94.
Id. at 96.
Id.
Id. at 101–04.
Id. at 101–03.
Id. at 103–04.
Sax & Doran, supra note 22.
Id.
See Altman, supra note 164.
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they have the capacity to invest in technology that tends to be more
“gentl[e] on the environment.”182
The information containing the scientific consensus about the
various technologies discussed in this article is available for the public
to read. The Center for Disease Control, for example, provides
information about the safety and efficacy of vaccines.183 It is not just
that the information be provided in order for the consumer to make a
decision—that is not sufficient. This is because a consumer can
perform an Internet search on “vaccines and autism” and locate
information, albeit incorrect, about a link between the two. Thus,
consumers receive contradictory and ambiguous information, and
they don’t know how to appropriately wade through all of it.184 In this
example, if a parent believes that his/her child might become autistic
due to vaccinations, s/he will feel “badness” in making a decision to
vaccinate. Therefore, the method of communication must take into
account affect and ambiguity, especially as we are in the information
age.
Even major scientific reports are unlikely to resolve the mass
amount of contradictory information provided to consumers. In May
2016, the National Academies of Science released a comprehensive
report about the health, safety and environmental friendliness of
genetically engineered food.185 Through a painstaking review of the
relevant literature, the National Academies of Science concluded the
following:
(1) Effect on Environment: “Overall, the committee found
no evidence of cause-and-effect relationships between GE
crops and environmental problems.”186
(2) Human Health: “[T]he research that has been
182

Jayson Lusk, Why Industrial Farms are Good for the Environment, N.Y. TIMES, Sept.
25, 2016, at SR4, http://www.nytimes.com/2016/09/25/opinion/sunday/whyindustrial-farms-are-good-for-the-environment.html?_r=0.
183
CDC, Vaccine Safety, supra note 48.
184
But see George Johnson, The Widening World of Hand-Picked Truths, N.Y. TIMES
(Aug. 24, 2015), http://www.nytimes.com/2015/08/25/science/the-widening-worldof-hand-picked-truths.html?_r=0 (“Google recently tweaked its algorithm so that
searching for ‘vaccination’ or ‘fluoridation,’ for example, brings vetted medical
information to the top of the results.”).
185
National Academy of Sciences, Genetically Engineered Crops: Experiences and
Prospects, THE NAT’L ACADEMIES PRESS (May 17, 2016), http://www.nap.edu/catalog/23
395/genetically-engineered-crops-experiences-and-prospects [hereinafter N.A.S.,
Genetically Engineered Crops]; see also Henry I. Miller, National Academy of Sciences ‘GMO’
Report Does Science no Favors, FORBES (May 24, 2016, 5:00 AM),
http://www.forbes.com/sites/henrymiller/2016/05/24/national-academy-ofsciences-gmo-data-dump-leaves-over-regulation-intact/#151a8d347a0b.
186
N.A.S., Genetically Engineered Crops, supra note 185, at 100.
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conducted in studies with animals and on chemical
composition of GE food reveals no differences that would
implicate a higher risk to human health from eating GE
foods than from eating their non-GE counterparts.”187
(3) Social and Economic Effects: “[E]xisting GE crops have
generally been useful to large scale farmers of cotton,
soybean, maize and canola. The same GE crops have
benefitted a number of small-scale farmers, but benefits have
varied widely across time and space, and are connected to the
institutional context in which the crops have been
deployed.”188
The National Academies Report essentially regurgitated much of
what scientists have known for a long time, but was equivocal at times,
citing the need for additional studies.189 Since the scientific process
necessarily leads to additional questions, some familiar in this field
have suggested that the calls for additional studies can be taken out of
context.190 Put differently, just because additional studies are needed
does not mean that we do not know enough to implement sensible
policies and regulations.
The issue is not only how to communicate the science of the
technology so that consumers have the factual information to
appropriately assign risk, but also how to combat false, ambiguous, or
misleading information. Since ambiguous information is available on
the Internet, it is not possible to provide only accurate information to
consumers. Instead, different platforms must be created to provide
correct information in a way that considers how consumers make
decisions.
Dread is an important feeling involved with risk perception.191
Recent studies demonstrate that “perceptions of risk and society’s
responses to risk were strongly linked to the degree to which a hazard
evoked feelings of dread. Thus, activities associated with cancer are
seen as riskier and more in need of regulation than activities associated
with less dreaded forms of illness, injury, and death (e.g., accidents).”192
Other studies analyzing the role of affect in decision-making show an
inverse relationship: “judgments of risk and benefit are negatively
187

Id. at 156.
Id. at 221; see also Strauss & Sax, supra note 82, at 476 (discussing how the time
and cost of the regulatory process impedes small farmers from taking advantage of the
technology).
189
Miller, supra note 185.
190
Id.
191
Slovic, The Affect Heuristic, supra note 14, at 1342 (internal citation omitted).
192
Id.
188
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correlated.”193 Results from studies showing this inverse relationship
suggest that “people base their judgments of an activity or a technology
not only on what they think about it but also what they feel about it. If
they like an activity, they are moved to judge the risks as low and the
benefits as high; if they dislike it, they tend to judge the opposite: high
risk and low benefit.”194
Another potential problem for policies that implement
technology is the recognition that scientific theories and paradigms
change over time. Science is about asking questions and testing
hypotheses. This process leads to major paradigm upheavals (compare
Newton to Einstein) and even smaller paradigm shifts (eating high-fat
food is not as bad as was once thought). To be fair, even if the correct
information is provided to consumers in a way that allows them to
assign risk, the application of scientific discovery will (and should) face
some healthy skepticism, especially given the incremental changes and
paradigm shifts. However, overall we live longer and healthier lives
compared to previous generations. So, the fear of the potential
unknowns in science should be evaluated within this larger context.
So, where do we go from here? This article proposes several
approaches for policymakers to consider, all of which use decisionmaking theories to assuage consumer concerns, allow consumers to
appropriately assign risk, and to make informed decisions. These
suggestions promote studying the influence and role of affect and
ambiguity as a component to drafting, adopting, and implementing
policy. Affect and ambiguity have not played a major role in the legal
policy arena.195 The studies described in Part II support the hypothesis
that affect and ambiguity are playing a role in how consumers are
responding to policies that implement biotechnology. Given that the
examples described in Part II—vaccines, GMOs, rbST, fluoridated
water, and embryonic stem cell research—are not controversial within
the scientific community, it is important to understand why consumers
perceive risks so differently than the experts. With large-scale
problems, such as climate change and health care, needing to be
193

Id.
Id. at 1343.
195
See Peters et al., supra note 36, at 79 (citation omitted) (“The field of judgment
and decision making (JDM) long neglected the influence of ‘hot processes’ on
decision behavior in favor of a focus on ‘cold,’ deliberative, and reason-based decision
making. Historically, this was due at least in part to hot processes being viewed
primarily as biased, leading to irrational choice behavior. However, over the last ten
years the JDM field has turned its attention more and more to how affective feelings
influence judgments and decisions. Today, emotion and affect are on the research
agenda for many JDM researchers.”).
194
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addressed, consumers’ perceptions of risk must come closer to the
actual risks as evaluated by experts. Otherwise, this tension will likely
increase and lead to the same type of rejection that has occurred with
nuclear energy.196
Based on the information described above, this article articulates
four themes that consider both what we already know and where we
should consider going. All four of these themes posit that affect and
ambiguity play important roles in obtaining consumer support for
policy implementation. Within each theme, this article describes
examples of possible future directions for studies by using vaccines,
GMOs, rbST, fluoridated water, and embryonic stem cell research as
test cases. This article briefly proposes examples of pilot studies that
can be conducted. While the general outline of ways to examine the
themes are discussed below, detailed studies that utilize software suites
dedicated to behavioral studies, large-scale consumer analyses and
other approaches could form the basis for grant applications and
potentially funded studies. The below discussion is meant to open a
dialogue and conversation for future directions and collaborations.
Some of the themes below have overlapping concerns for policy
implementation. An example of an overlapping concern is how to
address consumer autonomy in public health policy implementation,
such as vaccinations and fluoride in the water supply. On the other
hand, each area of technology poses individual or unique concerns.
While recombinant DNA technology forms the underlying
technological basis for both rbST and GMOs, these areas of
biotechnology face independent challenges in policy implementation.
To address the overlapping and individual issues, each example is
discussed within each of the themes. To highlight the differences, this
article suggests ways to conduct studies to test whether and how each
theme might apply to each example. The purpose of this is to stress
that: (1) a one-approach-fits-all will not work for implementation of
controversial areas of technology; and (2) future studies catered
towards each example that test the role of affect and ambiguity can be
conducted. The next few subsections are forward-thinking in that the
discussion herein can form the basis of future empirical studies.

196

See Walsh, supra note 11.
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A. Theme 1: Separate the Wheat from the Chaff: Allow Consumers to
make Informed Choices
First, informed decisions should be based on accurate
information.197 This problem is starkly seen in the vaccination wars.
VHPs resist vaccination based on concerns of linkage to autism,
irreversible harm, low likelihood of contracting the actual disease, and
perhaps an incorrect understanding of the devastating impact of the
vaccine-preventable disease.198 These beliefs are based on inaccurate
information; thus, the consumers are not making informed decisions.
While individual autonomy regarding the decision to vaccinate or not
presents major public health challenges, due to the requirement for
herd immunity, it may be possible to soften the resistance to
vaccinations simply by providing consumers with accurate
information. Studies should be aimed at testing how to provide
accurate information to consumers in a way that allows them to
appropriately assign risk. An example of a specific study could test
whether environmental differences impact how consumers receive and
process information. For example, would a mobile-nurse (or other
health care professional) visiting a family in their home to both
provide information and answer questions have an impact on decisionmaking, as compared to no home visit? Or, perhaps, could literature
about vaccines be provided via U.S. Mail prior to a doctor’s visit to assist
with providing accurate information to consumers? These prior visits
or mailings could be presented with a “happy” inference such that
consumers may experience some sort of positive feeling associated with
the information. This could be compared to simply providing
information at a doctor’s visit. This type of study incorporates both
affect and ambiguity in analyzing how consumers respond to the
presentation of accurate information.
In the debate surrounding GMOs, food labeling laws provide a
helpful example in which consumers seek to make informed decisions.
If consumers want to know information about their food, including the
source, then food labeling laws can respond to consumer needs.
During the past several years, at least thirty-five states have introduced
food labeling laws related to genetically engineered food.199 These laws
197

See Slovic, What’s Fear Got to Do with It?, supra note 36, at 989 (“It seems obvious
that designers of risk education and communication programs should work with
experts in these fields, yet this does not seem to be happening. Such collaboration
would help the government to work with the intended audience of each message.
Designers need to listen to the public’s concerns, collaborate in message development,
and test messages and programs to see if they are working as intended.”).
198
Blaisdell et al., supra note 19, at 483–85.
199
Sax & Doran, supra note 22.
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can certainly be neutral and allow consumers to have information.
The problem is that consumers make inappropriate associations with
various food labels.200 In one study, survey participants found the GMO
label to be less healthy, less safe, and less environmentally friendly
compared to a variety of other labels, including the labels “organic”
and “natural.”201 Since the label “natural” has no regulatory definition,
such a label does not provide information to consumers.202 But,
marketing companies know that consumers have positive associations
with the term “natural” and this is seen very prominently in the dietary
supplement industry.203 A recent episode of Keeping Up With the
Kardashians showed Kourtney Kardashian food shopping with her son.
In this episode, Ms. Kardashian found gum labeled “natural” and
seemed very pleased to offer this gum to her son. It would be
interesting to know if the ingredients in the gum labeled “natural”
differ compared to other commercial gum. Labels appear to matter to
consumers, which is completely fine, but the labels should provide
information in a way that allows consumers to make informed choices.
If consumers want to know that their food is healthy, for example, then
labels can respond to that concern. The problem is that the label
“natural,” for example, does not accurately provide that information,
but many consumers think that it does.204
In the GMO controversy, understanding consumer preferences
can allow policymakers to provide accurate information in a way that
responds to the consumer needs. For example, studies could divide
subjects into different groups and provide accurate information in a
way that responds to consumer preferences. Testing participant
responses via survey could be used to analyze whether the information
provided led to different responses. Put differently, policymakers need
to understand how to communicate with consumers so that the
200

Id.
Id.
202
“Natural”
on
Food
Labeling,
FOOD
&
DRUG
ADMIN.,
http://www.fda.gov/Food/GuidanceRegulation/GuidanceDocumentsRegulatoryInf
ormation/LabelingNutrition/ucm456090.htm (last updated May 9, 2016)
(responding to citizens petitions to try to establish a definition for the term “natural”).
203
See Joanna K. Sax, Dietary Supplements are Not all Safe and Not all Food: How the Low
Cost of Dietary Supplements Preys on the Consumer, 41 AM. J.L. & MED. 374, 377 (2015)
(internal citations omitted) (“Manufacturers exploit this preference in their
marketing techniques, by touting their supplement as ‘natural.’ The perception of
some consumers is that anything that is natural is safe. But, of course, that is not true.
Many poisonous and dangerous things are natural, such as wild mushrooms. Tobacco
is another natural ingredient that is linked to adverse health consequences.”).
204
See, e.g., Andrew Sullivan, Naturally Nonsense, THE DISH (June 25, 2014, 5:17 PM),
http://dish.andrewsullivan.com/2014/06/25/naturally-nonsense/.
201
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consumers can separate the wheat from the chaff. A specific study
could include statements by smaller farmers who want to use
biotechnology to address a niche problem in their area. Studies show
that consumers perceive organic farming as local and small, and like
the idea of a return to wholesomeness.205 Consumers may be surprised
to learn biotechnology can be used to solve niche problems, but that
it has been kept out of reach of small, local farmers due to the time
and expense associated with regulatory review.206 For consumers who
are concerned about sustainable farming, for example, they may be
interested to learn that the use of genetic engineering to solve a
distinct problem, such as a virus that infects crops in a particular area
of the country, is out of reach for some farmers, leading to crop loss.
Additional information about health and safety profiles of genetically
engineered food may also be illustrative to consumers.
By
understanding the preferences of consumers, information can be
provided in a way that accurately responds to these concerns. Perhaps
small farmers who want to use genetically engineered crops can reach
the consumers who are attracted to the same attributes that they
associate with local organic farming.207 Put differently, some of the
reasons that consumers chose to buy organic are also reasons to buy
food made from local farmers who want to use biotechnology to solve
a niche problem. Consumers may be unaware of the benefits of food
produced from GMOs. If consumers understand the application of
biotechnology, they may see the benefit as high and possibly assign a
lower probability of risk.
The controversy surrounding the treatment of dairy cows with
rbST overlaps with the GMO debates. To date, no scientific consensus
exists that treatment of cows with rbST causes health issues in humans.
But, consumers who see an “rbST-free” label might relate this label
with some sort of negative association, such as a health or safety issue;
i.e. with milk from cows treated with rbST. Empirical studies analyzing
consumer associations with rbST labels can easily be conducted, in a
similar fashion as the GMO labeling study described above. Additional
studies can be aimed at providing accurate information regarding
205

Hughner et al., supra note 72, at 101–03. See also, for example, a pro-organic
company called WHOLESOME!, http://wholesomesweet.com/ (last visited Nov. 23,
2016).
206
See Strauss & Sax, supra note 82, at 475 (internal citation omitted) (“This is a
major factor preventing most small companies and public sector breeders from using
GMO methods. . . . This recognizes that the current regulations have the practical
consequence of keeping innovations out of the marketplace, including more
environmentally friendly or healthy alternatives.”).
207
Control groups would also be included in any study.
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rbST treated cows in an attempt to see if this changes consumer
responses to various labels.
Fluoridated water programs are similar to vaccination programs
because of the widespread implementation. Adding fluoride to the
public water supply makes it very difficult for a consumer to opt out.
In addition, the risk of any adverse event from fluoride in the water is
very low and the public health benefit is very high.208 For this reason,
it is important to compare whether different methods of
communication that provide accurate information change the way
consumers make decisions. Whether consumers respond differently
can be tested using focus groups or responses to survey questions.
In the debate surrounding embryonic stem cell research,
consumers received conflicting and inaccurate information. As
discussed earlier, one study showed that mainstream newspapers
inaccurately reported that adult stem cells were equal to embryonic
stem cells, suggesting that research on embryonic stem cells was not
needed.209 It is unclear if consumers were used as pawns in a political
debate, but that is certainly an inference that can be made. In the past
fifteen years, scientists have learned much more about stem cells in
general. In some cases, adult stem cells do provide a better starting
material compared to embryonic stem cells and vice versa.210 This is
important information obtained through many years of research.211
Scientists do not know the answers until they test their hypotheses.
Consumers should be provided with information based on actual data
in order to make informed decisions about controversial areas of
funding. A longitudinal study analyzing consumer perceptions of
embryonic stem cell research over time might provide interesting
information to see if perceptions change as more information is
obtained.
When consumers do not understand the science, they are more
likely to inappropriately assign a high risk to that particular application
208

See generally supra Section II.D.
Sax, The Separation of Politics and Science, supra note 146, at 17.
210
Stem Cell Basics – What are the similarities and differences between embryonic and adult
stem cells?, NAT’L INSTS. OF HEALTH, http://stemcells.nih.gov/info/basics/pages/basics
5.aspx (last updated Mar. 3, 2015) (“Scientists believe that tissues derived from
embryonic and adult stem cells may differ in the likelihood of being rejected after
transplantation. . . . Adult stem cells, and tissues derived from them, are currently
believed less likely to initiate rejection after transplantation.”).
211
See, e.g., Stem Cell Basics – What are adult stem cells?, NAT’L INSTS. OF HEALTH,
http://stemcells.nih.gov/info/basics/pages/basics4.aspx (last updated June 17,
2015) (“In a variation of transdifferentiation experiments, scientists have recently
demonstrated that certain adult cell types can be ‘reprogrammed’ into other cell types
in vivo using a well-controlled process of genetic modification[.]”).
209
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of technology. Consumers should be in a position to make informed
decisions. The concern is that with so much conflicting information
available, it is challenging for a consumer to know what information to
use. Studies are needed to understand the best ways to provide
accurate information to consumers to allow them to be in a position to
appropriately assign the benefits and risks to a particular decision.212
B. Theme 2: Scientific Uncertainty is Different than Risk
Second, scientific uncertainty is part of the scientific process.
Unknowns always exist in science, but this is different than having
enough information to be able to assign a probability of risk.
Consumers may have trouble differentiating between scientific
uncertainty and risk. The question becomes how to communicate not
only the science, but also that some scientific uncertainty still allows
consumers to assign a risk. The American Association for the
Advancement of Science (AAAS) has dedicated significant efforts to
creating interactions between scientists and society.213 Corporations
and other interested actors are also testing and implementing
consumer outreach programs.214 Scientific uncertainty does not mean
that policymakers do not have enough information to make informed
policy decisions.
A physician may never be able to say that vaccines are 100 percent
safe all the time and that no adverse event could ever be related to a
vaccine. Some small risks exist. A small risk of infection, for example,
might occur at the injection site. This uncertainty however, pales in
comparison to the overwhelming amount of evidence regarding the
benefits of vaccines. An example of scientific uncertainty might be
testing and revisiting the best timing for administration of
immunization to allow patients to obtain the highest level of immunity.
This type of scientific uncertainty and need for ongoing studies should
not be confused with the overwhelming amount of evidence
demonstrating the efficacy of vaccines. Consumers may conflate risk
and uncertainty in the following way: a parent might believe that
because recommended doses and timing of those doses change, the
scientific community does not really understand what it is doing, and

212

The author is grateful to a colleague who used the terminology, separating
wheat from chaff, to describe an issue (although in another setting). This description
spurred the name for this theme.
213
See AAAS, supra note 171.
214
See, e.g., The Conversation, MONSANTO, http://discover.monsanto.com/
conversation/ (last visited May 24, 2016) (providing a forum for consumers to ask
questions).
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therefore assign a high risk to any vaccination protocol or
recommendation. To be fair, the skepticism of scientific uncertainty
may be greater in consumers due either to changes in medical advice
(for example, fat is not as bad as we once thought for our diets) or
larger paradigm shifts. But, as discussed earlier in this article, this must
be fairly balanced with overwhelming evidence that scientific advances
allow us to live longer and healthier lives compared to our ancestors.
The studies described within this article can provide important
insight regarding how consumers make decisions when the risks are
unknown. If consumers experience the feeling of dread, they are likely
to assign a high risk to the outcome.215 If consumers feel that the
administration of a vaccine to their children will cause major long-term
and irreversible problems, they may choose not to vaccinate.216
Perhaps because scientists and physicians may never be able to say that
vaccines are 100 percent safe, parents may experience a negative affect
if they think that their children would be part of the very small group
that has an adverse reaction. Would consumers feel differently about
the assignment of risk of a vaccine if it is placed in the context of other
types of risks? The risk of being killed in a driving accident is greater
than the risk of an adverse event from a vaccine.217 Studies can test
whether the negative feelings associated with particular decisions can
be adjusted by providing information about risk. Would consumers
feel differently about the assignment of risk if they understood the
difference between scientific uncertainty and risk? Studies are needed
to evaluate how to provide this type of information to consumers in
such a way.
The scientific consensus for food produced from GMOs is that it
is as safe as conventional food.218 It is possible that in the future some
215

Slovic, The Affect Heuristic, supra note 14, at 1342.
Cf. Blaisdell et al., supra note 19, at 483–85.
217
Compare
General
Statistics,
INS.
INST.
FOR
HIGHWAY
SAFETY,
http://www.iihs.org/iihs/topics/t/general-statistics/fatalityfacts/state-by-stateoverview (last visited June 11, 2016) (“There were 29,989 fatal motor vehicle crashes
in the United States in 2014 in which 32,675 deaths occurred.”), with Aaron
Sharockman, What CDC Statistics Say about Vaccine-Related Illnesses, Injuries and Death,
POLITIFACT (Feb. 3, 2015, 3:32 PM), http://www.politifact.com/punditfact/statements
/2015/feb/03/bob-sears/what-cdc-statistics-say-about-vaccine-illnesses-in/ (reporting
data on vaccine related deaths at 122 for the year 2014, with the VEARS disclaimer that
“[w]hen evaluating data from VAERS, it is important to note that for any reported
event, no cause-and-effect relationship has been established. Reports of all possible
associations between vaccines and adverse events (possible side effects) are filed in
VAERS. Therefore, VAERS collects data on any adverse event following vaccination,
be it coincidental or truly caused by a vaccine. The report of an adverse event to
VAERS is not documentation that a vaccine caused the event”).
218
See Press Release, supra note 93.
216
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type of conventional food or food produced from a GMO might not
be safe. This possibility is a scientific uncertainty, but should not be
used for risk assignment by consumers. Given the precise nature of
genetic engineering technology, a scientist might hypothesize that
genetically engineered food has a higher, or at least similar, likelihood
of safety compared to food produced from conventional methods.219
But, in practice, both of these types of food are safe. And, both types
of processes—genetic engineering and conventional methods—
should continue to be subject to scientific scrutiny. Given the many
decades of research comparing genetically engineered food to
conventional food, the safety risk of genetically engineered food is the
same as conventional food.220
In the rbST example, scientific studies indicate that humans who
consume milk have elevated levels of IGF-1.221 IGF-1, if unregulated,
can contribute to the risk of cancer.222 These studies also show that the
elevated levels of IGF-1 are found regardless of whether the milk is
from cows treated with rbST or not.223 Therefore, there is no evidence
suggesting a causal link between milk from rbST treated cows and
cancer in humans. Future scientific studies are needed to understand
why consumption of milk is associated with higher levels of IGF-1 in
humans. This scientific uncertainty is different from risk. In other
words, no adverse human health events are associated with rbST and,
the risk of developing cancer from drinking milk from cows treated
with rbST is similar to drinking milk from cows not treated with rbST.
The word “cancer” has been associated with strong affect in decisionmaking.224 Thus, it is likely that by using the word “cancer” or
insinuating “cancer” in association with milk treated with rbST in
advertising, marketing, or internet searches, consumers will

219

Cf. Conko et al., supra note 78, at 494 (“The essence of these principles is that
the mere fact that an organism has been modified by recombinant DNA or other
molecular techniques has no bearing on the degree of hazard or level of risk and
therefore should not determine whether (or how stringently) the organism is
regulated.”).
220
See supra Section II.B.
221
AM. CANCER SOC’Y, supra note 121; see also FDA Report on rBST, supra note 110.
222
See Herbert Yu & Thomas Rohan, Role of the Insulin-Like Growth Factor Family in
Cancer Development and Progression, 92 J. OF THE NAT’L CANCER INST. 1472, 1472 (2000)
(“Functionally, IGF-1 not only stimulates cell proliferation but also inhibits apoptosis.
It has now been recognized that the combination of these mitogenic and antiapoptotic
effects has a profound impact on tumor growth.”).
223
AM. CANCER SOC’Y, supra note 121.
224
Slovic, The Affect Heuristic, supra note 14, at 1342 (“Thus activities associated with
cancer are seen as riskier and more in need of regulation than activities associated with
less dreaded forms of illness, injury, and death (e.g. accidents).”).
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inappropriately assign risk. Empirical studies aimed at providing
consumers with the difference between scientific uncertainty and risk
may assist consumers with decision-making.
Some of the controversy surrounding fluoridated water relates to
using scientific uncertainty to incite fear. Over many decades,
scientists continued to research the optimal level of fluoride to add to
water. The recommendations have changed over time, with a decrease
in the optimal amount.225 This does not mean that scientists do not
understand what they are doing; rather, it means that scientists and
public health officials are monitoring and adjusting fluoride levels
based on data. The risk, however, of not fluoridating water is greater,
especially in poor populations which have less access to regular dental
care. Consumers who oppose fluoridation are weighing risks in the
wrong direction.
The debate surrounding embryonic stem cell research raises a
different concern compared to the other examples. One postulated
risk of this type of research could be (or could have been) exploiting
women for their eggs.226 Strict guidelines for egg donation were
created.227 Other risks with the application of therapies derived from
stem cell research are similar to the risks associated with clinical trials
for any experimental treatment. In addition, Institutional Review
Boards have specific guidelines to follow when proposed studies utilize
embryonic stem cells.228 It would be interesting to study whether
consumers view clinical trials using treatments derived from embryonic
stem cell research as riskier than clinical trials using other
experimental procedures. And, if consumers perceive greater risk with
225

Public Health Service Recommendation for Fluoride Concentration in
Drinking Water for Prevention of Dental Caries, 80 Fed. Reg. 24,936 (May 1, 2015),
https://www.gpo.gov/fdsys/pkg/FR-2015-05-01/pdf/2015-10201.pdf (“PHS now
recommends an optimal fluoride concentration of 0.7 milligrams/liter (mg/L).”).
226
See Erica Haimes et al., Eggs, Ethics and Exploitation? Investigating Women’s
Experiences of an Egg Sharing Scheme, 34 SOC. OF HEALTH & ILLNESS 1199, 1199 (2012)
(“In brief, our analysis suggests that while interviewees acknowledge the potential of
this scheme to be exploitative, they argue that this is not the case, emphasizing their
ability to act autonomously in deciding to volunteer. Nonetheless, these freely made
decisions do not necessarily take place under circumstances of their choosing. We
discuss the implications of this for egg provision in general and for understandings of
exploitation.”).
227
Stem Cell Information, National Institutes of Health Guidelines on Human Stem Cell
Research, NAT’L INSTS. OF HEALTH, http://stemcells.nih.gov/policy/pages/2009guide
lines.aspx (last updated Apr. 12, 2015).
228
Id.; see, e.g., Form for Egg Donation for Human Embryonic Stem Cell Research (Solely for
Stem Cell Research), N.Y. DEP’T OF HEALTH, http://stemcell.ny.gov/form-egg-donationhuman-embryonic-stem-cell-research-solely-stem-cell-research (last visited July 4,
2016).
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treatments from embryonic stem cell research, then it would be
valuable to know why that it so. In this way, information can be
communicated in order to allow consumers to appropriately assign
risk.
In sum, future studies can build on this and incorporate decisionmaking research to test how to provide information in a way that allows
consumers to appropriately assign risk, especially in the scientific arena
when unknowns exist.
C. Theme 3: Explore Different Methods of Communication that
Consider the Role of Affect and Ambiguity
Third, the role of affect and ambiguity should be specifically
considered in studies aimed at effective methods of communication.
While this is related to Theme 1 (discussed supra Part III.A), the
emphasis of Theme 3 is to address how to create studies to analyze the
different marketing forces, especially on the Internet, to understand
consumer decision-making. It is certainly not an original idea that
marketing impacts consumer decision-making or that industry takes
advantage of this. It is important, however, to conduct studies not only
to see how a particular industry or interest group utilizes affect and
ambiguity to steer consumers away from a particular area of
biotechnology, but to also test whether different approaches can be
used to combat a message that creates ambiguity or feelings of
“badness.” We know, for example, that consumers are more likely to
appropriately assign risk if they understand the science. We also know
that consumers are less likely to appropriately assign risk when they
receive ambiguous information. The question becomes how to
communicate the information in a way that recognizes the role of
affect and ambiguity.
Various approaches appear to be underway. An entire website
highlights stories about how VHPs changed their position once one of
their children contracted a vaccine-preventable disease.229 Recent
commentary in this area suggests that VHPs have little ability to weigh
the risks because of a lack of personal experience with the
consequences and complications associated with these diseases.230
Thus, the vaccine-preventable diseases, such as polio, measles and
229

Tara Hills, We Learned the Hard Way, VOICES FOR VACCINES (May 24, 2016),
http://www.voicesforvaccines.org/we-learned-the-hard-way/.
230
See, e.g., Emmi S. Herman, Measles and My Sister, VOICES FOR VACCINES (May 24,
2016), http://www.voicesforvaccines.org/measles-and-my-sister/ (“[T]oday’s parents
and physicians are less likely to have had any personal experience with the cruel
disease.”).
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mumps, may not seem real or deadly.231 But, once a parent sees his/
her child with the disease, the parent might feel differently about the
risk of vaccines. Using VHPs who changed their position might seem,
intuitively, as a good way to assist parents in assigning risks to
vaccinations.232 A former-VHP might be in a good position to reach a
current-VHP in a way that is different than how they might respond to
a pharmaceutical company. This type of approach should be
empirically tested to see if it has the desired response. Is it, for
example, impacting how VHPs make decisions? In other words, do
consumers respond differently to different sources that they perceive
as credible? Studies aimed at understanding how consumers respond
to different sources (and marketing related thereto) may provide
insight as how to allow consumers to appropriately assign risk. It is
important to compare how consumers respond to anti-vaccine
marketing techniques versus experimental pro-vaccine marketing
techniques. Understanding which techniques and why they are
effective (or ineffective) is important to communicate with consumers
(and marketing experts have known this for decades), but this theme
aims to suggest studies that utilize affect and ambiguity theories to
reach consumers in a way that gives them the ability to appropriately
assign risk.
Similarly, with GMOs, the question is: what is the most effective
method of communication regarding the application of the
technology? Studies aimed at comparing different messengers of the
technology—big corporations, publicly funded agriculture scientists,
small farmers, organic farmers (who may not oppose genetic
engineering technology), mothers, children, or others—could assist
with understanding how these communication methods allow
consumers to more appropriately assign risk. The experimental
conditions should be compared to the current marketing techniques
that consumers already experience. Studies aimed at digesting the role
of affect and ambiguity, especially if the credibility of sources is at issue,
will be important for communication tactics.
The controversy surrounding rbST has many similarities to
GMOs. Studies aimed at developing communication tactics that
consider affect and ambiguity as part of the decision-making process
need to be conducted. If consumers are concerned about animal
welfare, then perhaps veterinarians might be a potential messenger to
231

Cf. id.
For examples and stories of VHPs who changed their positions, see Anti-Vax to
Pro-Vax, VOICES FOR VACCINES (May 24, 2016), http://www.voicesforvaccines.org/
category/anti-vax-to-pro-vax/.
232
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provide accurate information regarding animal welfare. If consumers
are concerned about adverse human health consequences, scientists
and physicians might be good messengers. In these groups of
messengers, it would be interesting to compare variables, such as
whether the veterinarians, scientists and physicians are from
universities versus the private sector, or whether they receive their
financial support from the private sector or government grants. By
using techniques that allow for testing affect and ambiguity with these
different variables (including software aimed at behavioral research
studies), it may be possible for policymakers to provide accurate
information from trusted sources.
Fluoridated water programs suffer from the same issues described
above. Since most consumers are exposed to the public water supply
through homes, schools, restaurants, etc., it is important that
consumers make informed decisions about this public program. Fear
of adverse events associated with fluoridated water impacts decisionmaking. Studies aimed at examining how to provide accurate
information to consumers about fluoride are needed. An example of
a specific study might be to compare how consumers respond to a
widespread campaign of posting factual information using signs about
fluoridated water supplies in various public places, including post
offices, restaurants, hospitals, and grocery stores. Three sets of signs
can be designed: one set that suggests feelings of “goodness,” another
set that suggests feelings of “badness,” and a final set that does not
suggest a particular feeling. A fourth group would not see any signs.
Follow-up survey questions can compare consumer responses to
fluoridated water programs. If groups respond differently, this would
suggest that providing (or marketing) accurate information in a way
that incorporates affect impacts consumer decision-making.
Despite contemporary advances in medicine, we still currently
have many untreatable and highly debilitating diseases, such as
Alzheimer’s disease. Scientists hope that embryonic stem cell research
may open doors to create cures for currently un-curable diseases.233
Patients and family members are searching for treatments and cures
for highly debilitating diseases—often with the patient participating in
233

See, e.g., Stem Cell Basics – What are the potential uses of human stem cells and the
obstacles that must be overcome before these potential uses will be realized?, NAT’L INSTS. OF
HEALTH, http://stemcells.nih.gov/info/basics/pages/basics6.aspx (last updated Mar.
5, 2015) (“In people who suffer from type 1 diabetes, the cells of the pancreas that
normally produce insulin are destroyed by the patient’s own immune system. New
studies indicate that it may be possible to direct the differentiation of human
embryonic stem cells in cell culture to form insulin-producing cells that eventually
could be used in transplantation therapy for persons with diabetes.”).
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early clinical trials.234
It would be interesting to compare
communications from patients (and their family members),
physicians, and scientists to understand if consumers respond
differently. It may also be possible to separate out those that oppose
embryonic stem cell research for purely moral reasons versus those
that oppose embryonic stem cell research based on reasons related to
affect or ambiguity. Focus groups, similar to the study design used by
Blaisdell and colleagues, may provide helpful information to identify
underlying rationales.
The debates surrounding controversial biotechnology discussed
in this article suffer from communication and marketing issues.
Consumers are provided with conflicting information, often with
emotional undertones, which impacts their ability to assign risk to the
application of the underlying technology.235 Given consumer mistrust
of pharmaceutical companies, other tactics are needed to
communicate the risks and benefits to consumers.236 Is it possible for
big agricultural and pharmaceutical companies to build (or re-build)
the reputational value that other big companies, such as Costco,
appear to have with consumers?237 Would brand-enhancement in these
industries even have an impact? Studies can be conducted to compare
consumer perceptions of risk based on brand reputation. Or, perhaps,
are personal stories (by former VHPs, for example) more effective in
allowing consumers to assign risk? Or, are there particular celebrities
or other well-known people who could be influential by saying that
they, inter alia, vaccinate their children, or eat food from GMOs?
Future studies can assess the role of affect and ambiguity by comparing
various communications and marketing approaches.
234

See NIH Clinical Research Trials and You, The Basics, NAT’L INSTS. OF HEALTH,
https://www.nih.gov/health-information/nih-clinical-research-trials-you/basics (last
updated Apr. 29, 2016) (“Participants with an illness or disease also participate to help
others, but also to possibly receive the newest treatment and to have the additional
care and attention from the clinical trial staff. Clinical trials offer hope for many
people and an opportunity to help researchers find better treatments for others in the
future.”).
235
Cf. Johnson, supra note 184 (“A study published this month on the Proceedings
of the National Academy of Sciences suggested that it is more effective to appeal to
anti-vaxxers through their emotions, with stories and pictures of children sick with
measles, the mumps or rubella––a reminder that subjective feelings are still trusted
over scientific expertise.”).
236
See, e.g., Kessel, supra note 164, at 988–90.
237
Bryan Pearson, In Brand We Trust: How Recalls at Trader Joe’s, Costco, Can Enhance
Customer Engagement, FORBES (May 18, 2016, 4:33 PM), http://www.forbes.com/sites/
bryanpearson/2016/05/18/in-brand-we-trust-how-recalls-at-trader-joes-costco-canenhance-customer-engagement/#4661c92e77f4 (“Research shows there is an appetite
for brand reliability, even if it reveals fallibility.”).
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D. Theme 4: Address the Difference between Values, Affect and
Ambiguity in Decision-Making
This theme presents a particular challenge. How should
policymakers address conflicting information and differentiate
between value-based decisions and decisions impacted by affect and
ambiguity? The theory of evolution provides a nice example of this
dilemma. Evolution, for example, is probably the most accepted
scientific theory ever, yet the public perception is that scientists do not
have a consensus.238 A recent Pew Research survey showed:
While 98% of scientists connected to the American
Association for the Advancement of Science say they believe
humans evolved over time, only two-thirds (66%) of
Americans overall perceive that scientists generally agree
about evolution, according to 2014 data from a recent Pew
Research Center survey on science and society. Those in the
general public who reject evolution are divided on whether
there is a scientific consensus on the topic, with 47% saying
scientists agree on evolution and 46% saying they do not.239
Are consumers receiving conflicting information that leads them to
believe that scientists do not agree? If so, it is important to understand
where these consumers are receiving their information. Perhaps
consumers are receiving information from religious sources that
disagree with the scientific consensus.240 It becomes very difficult to
address how to tackle the presentation of conflicting information from
trusted sources, especially if individual values are at play. This is a
particular challenge for policymakers. Studies aimed at effectively
separating the role of affect and ambiguity from value-driven decisions
will be important for implementing evidence-based policies.
In the vaccination controversy, it is important to separate whether
VHPs are making value-based decisions or risk-based decisions. VHPs
may feel strongly about their position; that is, for them, it feels like a
value based decision. Or, the role of autonomy, certainly a legal value,
may be implicated in a VHP’s decision. Studies are needed to dissect
the difference between a value-based decision and a risk perception
decision. The value of autonomy presents major challenges in
238

See, e.g., David Masci, On Darwin Day, 5 Facts About the Evolution Debate, PEW RES.
CTR. (Feb. 12, 2016), http://www.pewresearch.org/fact-tank/2016/02/12/darwinday/.
239
Id.
240
Id. (“Of all the major religious groups in the U.S., evangelical Protestants are
among the most likely to reject evolution. According to the Religious Landscape
Study, a solid majority (57%) of evangelicals say humans and other living things have
always existed in their present form.”).
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implementing major public health policies. It is possible, however, to
try to understand whether VHPs believe they are making a value-based
versus risk-based decision. If it is possible to provide information in a
way that allows VHPs to appropriately assign risk to a decision to
vaccinate, then it is fair to characterize it as a risk-perception decision.
Accurate information can be provided to subjects regarding the risks
of vaccinating and non-vaccinating and then follow-on questions can
be presented to subjects that are framed as testing values versus risk
and comparing the answers.
While some of the resistance to GMOs may be due to an
inappropriate assignment of risk, another possibility is a moral/valuebased opposition to changing the DNA. Put differently, a value-based
opposition may be that science is interfering with “God’s design.”241
This is a particularly interesting value-based opposition because
conventional breeding also mutates DNA, albeit with less precision.
Once again, it is important to learn whether consumers are making
decisions based on values or perceptions of risk. Studies addressing
consumer concerns about health, safety and environment of food
produced from GMOs compared to understanding value-based
decisions will be important to understand the reasons underlying
consumer decision-making.
The controversy surrounding rbST does not appear to have the
same ethical or value-driven concerns as seen in other examples
discussed within this article. However, treatment of cows with rbST
certainly could raise these same types of issues because the rbST allows
cows to continue to produce milk in an artificial setting. Despite that
the public controversy around rbST is not cast in a value-driven
dialogue, it would still be interesting to test whether values are at play
in consumer decision-making. And, perhaps, a more interesting
question is to understand why this type of biotechnology has not
suffered from the same values-driven debate as vaccines, GMOs, and
embryonic stem cell research. Studies aimed at separating why some
forms of biotechnology are heavily value-laden or not may provide
powerful insight to address the more controversial examples provided
herein.
The controversy surrounding fluoridated water implicates the

241

Jonathan Frochtzwajg, Playing God? Many Faiths Agree that Tinkering with Genes is
Out of Bounds, THE GENETIC LITERACY PROJECT (May 7, 2015),
https://www.geneticliteracyproject.org/2015/05/07/playing-god-many-faiths-agreethat-tinkering-with-genes-is-out-of-bounds/ (“Religious views on GMOs are as varied as
religious traditions themselves, but there are some common theological threads. Chief
among them: the belief that to change genetic material is to play God.”).
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value of autonomy. Since it is very hard to opt out of exposure to the
public water supply, fluoridation programs violate individual
autonomy. The value of autonomy is not unlimited. As drivers on the
road, we cannot drive wherever we want; instead, we are required to
obey traffic rules. Rules that are meant to benefit the public often
violate individual autonomy.
For fluoridated water programs,
scientific data demonstrates that the benefit to the public greatly
exceeds any risk. Studies aimed at communicating fluoridated water
programs as similar to other public benefit programs may assist to
override an objection based on autonomy.
The debate about embryonic stem cell research highlights the
issues that arise with addressing the difference between decisions
based on values versus decisions that implicate affect and ambiguity.
In a previous study analyzing information provided to consumers
about federal funding of embryonic stem cell research, articles
(including editorials) in mainstream newspapers that suggested adult
stem cells could provide that same information as embryonic stem cells
was not supported by the scientific evidence at the time.242 Consumers
were asked to weigh-in on the funding of embryonic stem cell research,
but they were provided with contradictory information—that is, that
adult stem cells could provide similar information as embryonic stem
cells, thus avoiding the need to fund a controversial area of research.
Values and emotions related thereto were also incorporated in the
discussion. This is not to say that consumers cannot be opposed to
embryonic stem cell research; rather, a difference exists between a
value-based decision and a decision based on ambiguous information.
Put differently, a moral opposition is different than a decision based
on ambiguity.
E. The Role of Risk-Perception in Policymaking
Empirically testing ways to provide accurate information in a way
that considers consumer decision-making has some complications and
limitations. Accurately providing scientific information necessarily
means that there is always some degree of uncertainty. Opponents to
controversial biotechnology exploit scientific uncertainty. Simply
telling consumers that the unknown risks are likely small will not
assuage consumers and will not allow them to appropriately assign risk.
While factsheets by the Center for Disease Control, Food and Drug
Administration and National Institutes of Health are important, they
do not necessarily reach the weary and overwhelmed consumer. Since
242

Sax, The Separation of Politics and Science, supra note 146, at 7–14.
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consumers are wading through both information and misinformation,
various tactics have to be employed to allow consumers to make
informed choices. These tactics should utilize decision-making
research to provide information in a way that allows the consumer to
appropriately assign risk.
The above discussion should not be conflated with the issue that
scientific exploration should be ongoing. Some uncertainty exists
within well-accepted scientific theories—which necessitate additional
and ongoing research. But, this should not be confused with how
consumers assign risk. For example, an overwhelming amount of data
demonstrates that vaccines prevent death and disability from a variety
of diseases. This does not mean that research on safety and efficacy of
vaccines should end. The scientific community should continue to
research, revise, question, and improve vaccines. But, it does mean
that we have enough evidence to implement widespread vaccination
policies. Thus, while scientific research will continue on vaccines,
consumers should appropriately assign a low risk (and high benefit) to
standard vaccinations.
In line with ongoing scientific exploration, the policies
surrounding the applications of biotechnology should be analyzed and
revisited on an ongoing basis. Since scientific uncertainty exists,
additional studies will almost always be warranted. Government
officials, public health experts, physicians, and scientists must
collaborate to analyze issues from the basic sciences to change policies
on an on-going basis. Widespread implementation of policies—
especially as it relates to biotechnology—needs to be accomplished
with living documents. Risks must be minimized, but will likely never
be eliminated. Put differently, a small risk from a vaccine is still a much
smaller risk than not being vaccinated and developing a potentially
deadly disease. It is the risk/benefit ratio that needs to govern policies,
not whether any risk could exist at any time. Communicating
information in a manner that allows consumers to appropriately assign
risk is critical to addressing large-scale issues in health, safety, and the
environment.
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CONCLUSION
We have major societal challenges and problems to solve. This
article bridges together scientific studies, policy implementation, and
decision-making research particularly as to the role of affect and
ambiguity in consumer perceptions of risk. Understanding consumer
concerns is important to implementing wide-ranging policies,
especially in controversial areas such as biotechnology. Given that
some degree of scientific uncertainly always exists, it is important for
policy makers to communicate information in a way that allows
consumers to appropriately assign risk. By combining research from a
variety of disciplines, this article articulates common themes that run
through each area of consumer concerns. The thematic approach
provides general considerations for policy implementation. Within
each theme, specific studies are needed that are based on the data and
information that we already have about consumer resistance to certain
policies. By giving general suggestions of future studies, this article
highlights the distinct issues that face each specific area of technology,
particularly with respect to consumer concerns and decision-making.
This article compares how different studies may assist in
understanding how to address consumer decision-making and
provides a roadmap for future directions in this area.

